Thymulin

evidence_access

Full text obtained; relevant results/methods inspected. This does not assert exhaustive figure/data reanalysis.

experimental_condition

Zinc-matched control peptide exposure · Thymulin Condition belongs to the full experimental contrast; do not separate a joint intervention.

experimental_condition

Zinc-matched control equimolar zinc · Zinc(II) ion Condition belongs to the full experimental contrast; do not separate a joint intervention.

experimental_contrast

{"intervention": "Thymulin plus equimolar zinc", "comparator": "Zinc-matched control", "endpoint": "Mutation of an NF-kappa-B site in the mouse Il6 reporter removed the inhibitory reporter effect of thymulin treatment.", "effect_direction": "mixed", "combination": "joint", "conditions": [{"entity_slug": "thymulin", "state": "peptide exposure"}, {"entity_slug": "zinc-ion", "state": "equimolar zinc"}]} Explicit extracted experimental comparison; source-derived draft.

experimental_model

Mouse macrophages conditioned for one week, then challenged with LPS; human PBMC experiments used 24-hour pretreatment and are separate.

interpretation_status

Source-derived extraction of a fact-checked reference; access is explicit, not independent raw-data verification.

limitations

Interpret only within the recorded preparation, exposure and comparator. The complete source passage retains qualifications; unspecified doses/timing have not been extracted here. No clinical efficacy, nutrient deficiency or unique molecular mediation is inferred.

plain_language

Mutation of an NF-kappa-B site in the mouse Il6 reporter removed the inhibitory reporter effect of thymulin treatment.

primary_references

Thymulin restrains age-associated myeloid inflammation and enhances cancer immunotherapy. | 2026 | DOI 10.1038/s41467-026-75383-0 | PMID 42481458 | https://www.nature.com/articles/s41467-026-75383-0

source_locator

Reviewed reference lines 78-78; exact primary location described in quoted passage where extracted.

Thymulin: detailed mechanisms of action (reviewed 3 October 2026) · lines 78–78

Original AI-assisted review of primary studies and, where relevant, official regulatory records. Access level is retained per claim. Corrections, null results and unresolved questions remain explicit. Not publisher full text or independent replication. · supports · Mouse macrophages conditioned for one week, then challenged with LPS; human PBMC experiments used 24-hour pretreatment and are separate. · Recorded from source · Recorded from source

The 2026 Nature Communications study used **thymulin plus equimolar zinc versus zinc-matched controls**. Human PBMCs received 24-hour treatment before stimulated cytokine assessment. Mouse macrophages were conditioned during a week of differentiation, then challenged with LPS. Reduced IκBα phosphorylation, p65 DNA binding and inflammatory cytokine responses were reported. Mutation of an NF-κB site in an Il6 reporter removed the inhibitory reporter effect.

evidence_access

Full text obtained; relevant results/methods inspected. This does not assert exhaustive figure/data reanalysis.

experimental_condition

Zinc-matched control peptide exposure · Thymulin Condition belongs to the full experimental contrast; do not separate a joint intervention.

experimental_condition

Zinc-matched control equimolar zinc · Zinc(II) ion Condition belongs to the full experimental contrast; do not separate a joint intervention.

experimental_contrast

{"intervention": "Thymulin plus equimolar zinc", "comparator": "Zinc-matched control", "endpoint": "Thymulin with equimolar zinc reduced I-kappa-B-alpha phosphorylation and p65 DNA binding in conditioned mouse macrophages.", "effect_direction": "decrease", "combination": "joint", "conditions": [{"entity_slug": "thymulin", "state": "peptide exposure"}, {"entity_slug": "zinc-ion", "state": "equimolar zinc"}]} Explicit extracted experimental comparison; source-derived draft.

experimental_model

Mouse macrophages conditioned for one week, then challenged with LPS; human PBMC experiments used 24-hour pretreatment and are separate.

interpretation_status

Source-derived extraction of a fact-checked reference; access is explicit, not independent raw-data verification.

limitations

Interpret only within the recorded preparation, exposure and comparator. The complete source passage retains qualifications; unspecified doses/timing have not been extracted here. No clinical efficacy, nutrient deficiency or unique molecular mediation is inferred.

plain_language

Thymulin with equimolar zinc reduced I-kappa-B-alpha phosphorylation and p65 DNA binding in conditioned mouse macrophages.

primary_references

Thymulin restrains age-associated myeloid inflammation and enhances cancer immunotherapy. | 2026 | DOI 10.1038/s41467-026-75383-0 | PMID 42481458 | https://www.nature.com/articles/s41467-026-75383-0

source_locator

Reviewed reference lines 78-78; exact primary location described in quoted passage where extracted.

Thymulin: detailed mechanisms of action (reviewed 3 October 2026) · lines 78–78

Original AI-assisted review of primary studies and, where relevant, official regulatory records. Access level is retained per claim. Corrections, null results and unresolved questions remain explicit. Not publisher full text or independent replication. · supports · Mouse macrophages conditioned for one week, then challenged with LPS; human PBMC experiments used 24-hour pretreatment and are separate. · Recorded from source · Recorded from source

The 2026 Nature Communications study used **thymulin plus equimolar zinc versus zinc-matched controls**. Human PBMCs received 24-hour treatment before stimulated cytokine assessment. Mouse macrophages were conditioned during a week of differentiation, then challenged with LPS. Reduced IκBα phosphorylation, p65 DNA binding and inflammatory cytokine responses were reported. Mutation of an NF-κB site in an Il6 reporter removed the inhibitory reporter effect.

evidence_access

Full text obtained; relevant results/methods inspected. This does not assert exhaustive figure/data reanalysis.

experimental_condition

Zinc-matched control peptide exposure · Thymulin Condition belongs to the full experimental contrast; do not separate a joint intervention.

experimental_condition

Zinc-matched control equimolar zinc · Zinc(II) ion Condition belongs to the full experimental contrast; do not separate a joint intervention.

experimental_contrast

{"intervention": "Thymulin regimen", "comparator": "Zinc-matched control", "endpoint": "Thymulin treatment improved antitumor immune responses and anti-PD-L1 responsiveness in aged tumor-bearing mice.", "effect_direction": "increase", "combination": "joint", "conditions": [{"entity_slug": "thymulin", "state": "peptide exposure"}, {"entity_slug": "zinc-ion", "state": "equimolar zinc"}]} Explicit extracted experimental comparison; source-derived draft.

experimental_model

Aged mouse tumors; thymulin plus equimolar zinc versus zinc-matched controls, including anti-PD-L1 combinations.

interpretation_status

Source-derived extraction of a fact-checked reference; access is explicit, not independent raw-data verification.

limitations

Interpret only within the recorded preparation, exposure and comparator. The complete source passage retains qualifications; unspecified doses/timing have not been extracted here. No clinical efficacy, nutrient deficiency or unique molecular mediation is inferred.

plain_language

Thymulin treatment improved antitumor immune responses and anti-PD-L1 responsiveness in aged tumor-bearing mice.

primary_references

Thymulin restrains age-associated myeloid inflammation and enhances cancer immunotherapy. | 2026 | DOI 10.1038/s41467-026-75383-0 | PMID 42481458 | https://www.nature.com/articles/s41467-026-75383-0

source_locator

Reviewed reference lines 80-80; exact primary location described in quoted passage where extracted.

Thymulin: detailed mechanisms of action (reviewed 3 October 2026) · lines 80–80

Original AI-assisted review of primary studies and, where relevant, official regulatory records. Access level is retained per claim. Corrections, null results and unresolved questions remain explicit. Not publisher full text or independent replication. · supports · Aged mouse tumors; thymulin plus equimolar zinc versus zinc-matched controls, including anti-PD-L1 combinations. · Recorded from source · Recorded from source

In aged tumor-bearing mice, treatment improved antitumor immune responses and anti-PD-L1 responsiveness. These findings support a downstream NF-κB-associated mechanism in those models. They do not demonstrate immediate direct inhibition of IKK, identify a thymulin receptor, show human cancer efficacy, or establish zinc deficiency as the cause of the tumors. [2026 primary study](https://www.nature.com/articles/s41467-026-75383-0)

evidence_access

Primary bibliographic record and abstract checked; full methods/figures not comprehensively reviewed.

experimental_condition

LPS-matched control peptide exposure · Thymulin Condition belongs to the full experimental contrast; do not separate a joint intervention.

experimental_contrast

{"intervention": "Thymulin plus LPS", "comparator": "LPS-matched control", "endpoint": "Thymulin increased cAMP in LPS-challenged fetal rat alveolar type II cells.", "effect_direction": "increase", "combination": "joint", "conditions": [{"entity_slug": "thymulin", "state": "peptide exposure"}, {"entity_slug": null, "state": "LPS challenge"}]} Explicit extracted experimental comparison; source-derived draft.

experimental_model

Fetal rat alveolar type II cells challenged with LPS; zinc-alone controls also affected cytokines. Distinct from the retracted hippocampal paper.

interpretation_status

Source-derived extraction of a fact-checked reference; access is explicit, not independent raw-data verification.

limitations

Interpret only within the recorded preparation, exposure and comparator. The complete source passage retains qualifications; unspecified doses/timing have not been extracted here. No clinical efficacy, nutrient deficiency or unique molecular mediation is inferred.

plain_language

Thymulin increased cAMP in LPS-challenged fetal rat alveolar type II cells.

primary_references

Thymulin and zinc (Zn2+)-mediated inhibition of endotoxin-induced production of proinflammatory cytokines and NF-kappaB nuclear translocation and activation in the alveolar epithelium: unraveling the molecular immunomodulatory, anti-inflammatory effect of thymulin/Zn2+ in vitro. | 2009 | DOI 10.1016/j.molimm.2009.09.034 | PMID 19850345 | https://pubmed.ncbi.nlm.nih.gov/19850345/

source_locator

Reviewed reference lines 69-69; exact primary location described in quoted passage where extracted.

Thymulin: detailed mechanisms of action (reviewed 3 October 2026) · lines 69–69

Original AI-assisted review of primary studies and, where relevant, official regulatory records. Access level is retained per claim. Corrections, null results and unresolved questions remain explicit. Not publisher full text or independent replication. · supports · Fetal rat alveolar type II cells challenged with LPS; zinc-alone controls also affected cytokines. Distinct from the retracted hippocampal paper. · Recorded from source · Recorded from source

| Fetal rat alveolar type II cells challenged with LPS | Thymulin increased cAMP, reduced NF-κB nuclear signaling and reduced IL-1β release; IL-6 and TNF-α were not similarly suppressed. | Zinc alone also changed cytokine outputs. cAMP-associated effects do not identify a GPCR or establish sole mediation. This paper is not the retracted hippocampal paper discussed below. [2009 experiment](https://pubmed.ncbi.nlm.nih.gov/19850345/) |

evidence_access

Primary bibliographic record and abstract checked; full methods/figures not comprehensively reviewed.

experimental_condition

LPS-matched control peptide exposure · Thymulin Condition belongs to the full experimental contrast; do not separate a joint intervention.

experimental_contrast

{"intervention": "Thymulin plus LPS", "comparator": "LPS-matched control", "endpoint": "Thymulin reduced IL-1 beta release in LPS-challenged fetal rat alveolar type II cells.", "effect_direction": "decrease", "combination": "joint", "conditions": [{"entity_slug": "thymulin", "state": "peptide exposure"}, {"entity_slug": null, "state": "LPS challenge"}]} Explicit extracted experimental comparison; source-derived draft.

experimental_model

Fetal rat alveolar type II cells challenged with LPS; zinc-alone controls also affected cytokines. Distinct from the retracted hippocampal paper.

interpretation_status

Source-derived extraction of a fact-checked reference; access is explicit, not independent raw-data verification.

limitations

Interpret only within the recorded preparation, exposure and comparator. The complete source passage retains qualifications; unspecified doses/timing have not been extracted here. No clinical efficacy, nutrient deficiency or unique molecular mediation is inferred.

plain_language

Thymulin reduced IL-1 beta release in LPS-challenged fetal rat alveolar type II cells.

primary_references

Thymulin and zinc (Zn2+)-mediated inhibition of endotoxin-induced production of proinflammatory cytokines and NF-kappaB nuclear translocation and activation in the alveolar epithelium: unraveling the molecular immunomodulatory, anti-inflammatory effect of thymulin/Zn2+ in vitro. | 2009 | DOI 10.1016/j.molimm.2009.09.034 | PMID 19850345 | https://pubmed.ncbi.nlm.nih.gov/19850345/

source_locator

Reviewed reference lines 69-69; exact primary location described in quoted passage where extracted.

Thymulin: detailed mechanisms of action (reviewed 3 October 2026) · lines 69–69

Original AI-assisted review of primary studies and, where relevant, official regulatory records. Access level is retained per claim. Corrections, null results and unresolved questions remain explicit. Not publisher full text or independent replication. · supports · Fetal rat alveolar type II cells challenged with LPS; zinc-alone controls also affected cytokines. Distinct from the retracted hippocampal paper. · Recorded from source · Recorded from source

| Fetal rat alveolar type II cells challenged with LPS | Thymulin increased cAMP, reduced NF-κB nuclear signaling and reduced IL-1β release; IL-6 and TNF-α were not similarly suppressed. | Zinc alone also changed cytokine outputs. cAMP-associated effects do not identify a GPCR or establish sole mediation. This paper is not the retracted hippocampal paper discussed below. [2009 experiment](https://pubmed.ncbi.nlm.nih.gov/19850345/) |

evidence_access

Primary bibliographic record and abstract checked; full methods/figures not comprehensively reviewed.

experimental_condition

LPS-matched control peptide exposure · Thymulin Condition belongs to the full experimental contrast; do not separate a joint intervention.

experimental_contrast

{"intervention": "Thymulin plus LPS", "comparator": "LPS-matched control", "endpoint": "IL-6 was not similarly suppressed by thymulin in LPS-challenged fetal rat alveolar type II cells.", "effect_direction": "no_detected_change", "combination": "joint", "conditions": [{"entity_slug": "thymulin", "state": "peptide exposure"}, {"entity_slug": null, "state": "LPS challenge"}]} Explicit extracted experimental comparison; source-derived draft.

experimental_model

Fetal rat alveolar type II cells challenged with LPS; zinc-alone controls also affected cytokines. Distinct from the retracted hippocampal paper.

interpretation_status

Source-derived extraction of a fact-checked reference; access is explicit, not independent raw-data verification.

limitations

Interpret only within the recorded preparation, exposure and comparator. The complete source passage retains qualifications; unspecified doses/timing have not been extracted here. No clinical efficacy, nutrient deficiency or unique molecular mediation is inferred.

plain_language

IL-6 was not similarly suppressed by thymulin in LPS-challenged fetal rat alveolar type II cells.

primary_references

Thymulin and zinc (Zn2+)-mediated inhibition of endotoxin-induced production of proinflammatory cytokines and NF-kappaB nuclear translocation and activation in the alveolar epithelium: unraveling the molecular immunomodulatory, anti-inflammatory effect of thymulin/Zn2+ in vitro. | 2009 | DOI 10.1016/j.molimm.2009.09.034 | PMID 19850345 | https://pubmed.ncbi.nlm.nih.gov/19850345/

source_locator

Reviewed reference lines 69-69; exact primary location described in quoted passage where extracted.

Thymulin: detailed mechanisms of action (reviewed 3 October 2026) · lines 69–69

Original AI-assisted review of primary studies and, where relevant, official regulatory records. Access level is retained per claim. Corrections, null results and unresolved questions remain explicit. Not publisher full text or independent replication. · supports · Fetal rat alveolar type II cells challenged with LPS; zinc-alone controls also affected cytokines. Distinct from the retracted hippocampal paper. · Recorded from source · Recorded from source

| Fetal rat alveolar type II cells challenged with LPS | Thymulin increased cAMP, reduced NF-κB nuclear signaling and reduced IL-1β release; IL-6 and TNF-α were not similarly suppressed. | Zinc alone also changed cytokine outputs. cAMP-associated effects do not identify a GPCR or establish sole mediation. This paper is not the retracted hippocampal paper discussed below. [2009 experiment](https://pubmed.ncbi.nlm.nih.gov/19850345/) |

evidence_access

Primary bibliographic record and abstract checked; full methods/figures not comprehensively reviewed.

experimental_condition

LPS-matched control peptide exposure · Thymulin Condition belongs to the full experimental contrast; do not separate a joint intervention.

experimental_contrast

{"intervention": "Thymulin plus LPS", "comparator": "LPS-matched control", "endpoint": "Thymulin reduced NF-kappa-B nuclear signaling in LPS-challenged fetal rat alveolar type II cells.", "effect_direction": "decrease", "combination": "joint", "conditions": [{"entity_slug": "thymulin", "state": "peptide exposure"}, {"entity_slug": null, "state": "LPS challenge"}]} Explicit extracted experimental comparison; source-derived draft.

experimental_model

Fetal rat alveolar type II cells challenged with LPS; zinc-alone controls also affected cytokines. Distinct from the retracted hippocampal paper.

interpretation_status

Source-derived extraction of a fact-checked reference; access is explicit, not independent raw-data verification.

limitations

Interpret only within the recorded preparation, exposure and comparator. The complete source passage retains qualifications; unspecified doses/timing have not been extracted here. No clinical efficacy, nutrient deficiency or unique molecular mediation is inferred.

plain_language

Thymulin reduced NF-kappa-B nuclear signaling in LPS-challenged fetal rat alveolar type II cells.

primary_references

Thymulin and zinc (Zn2+)-mediated inhibition of endotoxin-induced production of proinflammatory cytokines and NF-kappaB nuclear translocation and activation in the alveolar epithelium: unraveling the molecular immunomodulatory, anti-inflammatory effect of thymulin/Zn2+ in vitro. | 2009 | DOI 10.1016/j.molimm.2009.09.034 | PMID 19850345 | https://pubmed.ncbi.nlm.nih.gov/19850345/

source_locator

Reviewed reference lines 69-69; exact primary location described in quoted passage where extracted.

Thymulin: detailed mechanisms of action (reviewed 3 October 2026) · lines 69–69

Original AI-assisted review of primary studies and, where relevant, official regulatory records. Access level is retained per claim. Corrections, null results and unresolved questions remain explicit. Not publisher full text or independent replication. · supports · Fetal rat alveolar type II cells challenged with LPS; zinc-alone controls also affected cytokines. Distinct from the retracted hippocampal paper. · Recorded from source · Recorded from source

| Fetal rat alveolar type II cells challenged with LPS | Thymulin increased cAMP, reduced NF-κB nuclear signaling and reduced IL-1β release; IL-6 and TNF-α were not similarly suppressed. | Zinc alone also changed cytokine outputs. cAMP-associated effects do not identify a GPCR or establish sole mediation. This paper is not the retracted hippocampal paper discussed below. [2009 experiment](https://pubmed.ncbi.nlm.nih.gov/19850345/) |

evidence_access

Primary bibliographic record and abstract checked; full methods/figures not comprehensively reviewed.

experimental_condition

LPS-matched control peptide exposure · Thymulin Condition belongs to the full experimental contrast; do not separate a joint intervention.

experimental_contrast

{"intervention": "Thymulin plus LPS", "comparator": "LPS-matched control", "endpoint": "TNF-alpha was not similarly suppressed by thymulin in LPS-challenged fetal rat alveolar type II cells.", "effect_direction": "no_detected_change", "combination": "joint", "conditions": [{"entity_slug": "thymulin", "state": "peptide exposure"}, {"entity_slug": null, "state": "LPS challenge"}]} Explicit extracted experimental comparison; source-derived draft.

experimental_model

Fetal rat alveolar type II cells challenged with LPS; zinc-alone controls also affected cytokines. Distinct from the retracted hippocampal paper.

interpretation_status

Source-derived extraction of a fact-checked reference; access is explicit, not independent raw-data verification.

limitations

Interpret only within the recorded preparation, exposure and comparator. The complete source passage retains qualifications; unspecified doses/timing have not been extracted here. No clinical efficacy, nutrient deficiency or unique molecular mediation is inferred.

plain_language

TNF-alpha was not similarly suppressed by thymulin in LPS-challenged fetal rat alveolar type II cells.

primary_references

Thymulin and zinc (Zn2+)-mediated inhibition of endotoxin-induced production of proinflammatory cytokines and NF-kappaB nuclear translocation and activation in the alveolar epithelium: unraveling the molecular immunomodulatory, anti-inflammatory effect of thymulin/Zn2+ in vitro. | 2009 | DOI 10.1016/j.molimm.2009.09.034 | PMID 19850345 | https://pubmed.ncbi.nlm.nih.gov/19850345/

source_locator

Reviewed reference lines 69-69; exact primary location described in quoted passage where extracted.

Thymulin: detailed mechanisms of action (reviewed 3 October 2026) · lines 69–69

Original AI-assisted review of primary studies and, where relevant, official regulatory records. Access level is retained per claim. Corrections, null results and unresolved questions remain explicit. Not publisher full text or independent replication. · supports · Fetal rat alveolar type II cells challenged with LPS; zinc-alone controls also affected cytokines. Distinct from the retracted hippocampal paper. · Recorded from source · Recorded from source

| Fetal rat alveolar type II cells challenged with LPS | Thymulin increased cAMP, reduced NF-κB nuclear signaling and reduced IL-1β release; IL-6 and TNF-α were not similarly suppressed. | Zinc alone also changed cytokine outputs. cAMP-associated effects do not identify a GPCR or establish sole mediation. This paper is not the retracted hippocampal paper discussed below. [2009 experiment](https://pubmed.ncbi.nlm.nih.gov/19850345/) |

evidence_access

Primary bibliographic record and abstract checked; full methods/figures not comprehensively reviewed.

experimental_contrast

{"intervention": "Thymulin in normal versus hypothyroid chickens", "comparator": "Corresponding strain controls", "endpoint": "Thymulin produced opposite IL-2-receptor-positive lymphocyte responses in normal versus hypothyroid chicken strains.", "effect_direction": "mixed", "combination": "single", "conditions": []} Explicit extracted experimental comparison; source-derived draft.

experimental_model

Avian lymphocytes; normal and hypothyroid strains, not human efficacy.

interpretation_status

Source-derived extraction of a fact-checked reference; access is explicit, not independent raw-data verification.

limitations

Interpret only within the recorded preparation, exposure and comparator. The complete source passage retains qualifications; unspecified doses/timing have not been extracted here. No clinical efficacy, nutrient deficiency or unique molecular mediation is inferred.

plain_language

Thymulin produced opposite IL-2-receptor-positive lymphocyte responses in normal versus hypothyroid chicken strains.

primary_references

The effect of thymulin on avian IL-2 receptor expression. | 2000 | DOI 10.1016/s0192-0561(00)00051-5 | PMID 11090697 | https://pubmed.ncbi.nlm.nih.gov/11090697/

source_locator

Reviewed reference lines 58-58; exact primary location described in quoted passage where extracted.

Thymulin: detailed mechanisms of action (reviewed 3 October 2026) · lines 58–58

Original AI-assisted review of primary studies and, where relevant, official regulatory records. Access level is retained per claim. Corrections, null results and unresolved questions remain explicit. Not publisher full text or independent replication. · supports · Avian lymphocytes; normal and hypothyroid strains, not human efficacy. · Recorded from source · Recorded from source

Context dependence extends to target-cell markers: an avian study reported opposite changes in the proportion of IL-2-receptor-positive lymphocytes in normal versus hypothyroid chicken strains. This cannot be transferred directly to human disease, but it prevents a universal “thymulin increases IL-2 receptors” rule. [Avian IL-2-receptor experiment](https://pubmed.ncbi.nlm.nih.gov/11090697/)

evidence_access

Primary abstract plus selected publisher results inspected; full XML not obtained.

experimental_condition

Matched experimental control peptide exposure · Thymulin Condition belongs to the full experimental contrast; do not separate a joint intervention.

experimental_condition

Matched experimental control joint zinc exposure · Zinc(II) ion Condition belongs to the full experimental contrast; do not separate a joint intervention.

experimental_contrast

{"intervention": "Combined thymulin and zinc", "comparator": "Matched experimental control", "endpoint": "Combined thymulin/zinc increased IL-6 in the developmental lung experiments.", "effect_direction": "increase", "combination": "joint", "conditions": [{"entity_slug": "thymulin", "state": "peptide exposure"}, {"entity_slug": "zinc-ion", "state": "joint zinc exposure"}]} Explicit extracted experimental comparison; source-derived draft.

experimental_model

Fetal rat lung explants; A549 cells studied separately; oxygen-dependent conditions and endpoints retained in source.

interpretation_status

Source-derived extraction of a fact-checked reference; access is explicit, not independent raw-data verification.

limitations

Interpret only within the recorded preparation, exposure and comparator. The complete source passage retains qualifications; unspecified doses/timing have not been extracted here. No clinical efficacy, nutrient deficiency or unique molecular mediation is inferred.

plain_language

Combined thymulin/zinc increased IL-6 in the developmental lung experiments.

primary_references

Thymulin evokes IL-6-C/EBPbeta regenerative repair and TNF-alpha silencing during endotoxin exposure in fetal lung explants. | 2004 | DOI 10.1152/ajplung.00401.2002 | PMID 12639846 | https://doi.org/10.1152/ajplung.00401.2002

source_locator

Reviewed reference lines 70-70; exact primary location described in quoted passage where extracted.

Thymulin: detailed mechanisms of action (reviewed 3 October 2026) · lines 70–70

Original AI-assisted review of primary studies and, where relevant, official regulatory records. Access level is retained per claim. Corrections, null results and unresolved questions remain explicit. Not publisher full text or independent replication. · supports · Fetal rat lung explants; A549 cells studied separately; oxygen-dependent conditions and endpoints retained in source. · Recorded from source · Recorded from source

| Fetal rat lung explants and A549 lung cells, oxygen-dependent conditions | Combined thymulin/zinc exposure increased IL-6 and reduced TNF protein, with p38/MAPKAPK2 and transcription-factor responses. In explants, IL-6 antisense interfered with mesenchymal growth and FGF9-associated effects. | Increased IL-6 here is a developmental response; TNF transcript and protein need separate records. Joint peptide/zinc treatment cannot automatically be attributed to peptide alone. [2004 experiment](https://doi.org/10.1152/ajplung.00401.2002) |

evidence_access

Primary bibliographic record and abstract checked; full methods/figures not comprehensively reviewed.

experimental_contrast

{"intervention": "Neonatal thymulin immunoneutralization", "comparator": "Non-neutralized control", "endpoint": "Neonatal thymulin immunoneutralization reduced later circulating LH/FSH in mice; engineered met-FTS protected gonadotropin output in thymus-deficient mice.", "effect_direction": "decrease", "combination": "single", "conditions": []} Explicit extracted experimental comparison; source-derived draft.

experimental_model

Neonatal immunoneutralization and engineered rescue in mouse models; separate from adult dietary depletion.

interpretation_status

Source-derived extraction of a fact-checked reference; access is explicit, not independent raw-data verification.

limitations

Interpret only within the recorded preparation, exposure and comparator. The complete source passage retains qualifications; unspecified doses/timing have not been extracted here. No clinical efficacy, nutrient deficiency or unique molecular mediation is inferred.

plain_language

Neonatal thymulin immunoneutralization reduced later circulating LH/FSH in mice; engineered met-FTS protected gonadotropin output in thymus-deficient mice.

primary_references

Thymulin gene therapy prevents the reduction in circulating gonadotropins induced by thymulin deficiency in mice. | 2007 | DOI 10.1152/ajpendo.00085.2007 | PMID 17389714 | https://doi.org/10.1152/ajpendo.00085.2007

source_locator

Reviewed reference lines 110-110; exact primary location described in quoted passage where extracted.

Thymulin: detailed mechanisms of action (reviewed 3 October 2026) · lines 110–110

Original AI-assisted review of primary studies and, where relevant, official regulatory records. Access level is retained per claim. Corrections, null results and unresolved questions remain explicit. Not publisher full text or independent replication. · supports · Neonatal immunoneutralization and engineered rescue in mouse models; separate from adult dietary depletion. · Recorded from source · Recorded from source

There is also an experimental loss-of-function result: neonatal thymulin immunoneutralization in mice reduced later circulating LH/FSH, while engineered met-FTS delivery protected gonadotropin output in thymus-deficient mice. This supports a developmental endocrine role in those models; it is not equivalent to adult dietary zinc deficiency or an established human infertility mechanism. [2007 study](https://doi.org/10.1152/ajpendo.00085.2007)

evidence_access

Primary abstract plus selected publisher results inspected; full XML not obtained.

experimental_condition

Matched experimental control peptide exposure · Thymulin Condition belongs to the full experimental contrast; do not separate a joint intervention.

experimental_condition

Matched experimental control joint zinc exposure · Zinc(II) ion Condition belongs to the full experimental contrast; do not separate a joint intervention.

experimental_contrast

{"intervention": "Combined thymulin and zinc", "comparator": "Matched experimental control", "endpoint": "Combined thymulin/zinc reduced TNF protein in the developmental lung experiments; transcript and protein effects must remain separate.", "effect_direction": "decrease", "combination": "joint", "conditions": [{"entity_slug": "thymulin", "state": "peptide exposure"}, {"entity_slug": "zinc-ion", "state": "joint zinc exposure"}]} Explicit extracted experimental comparison; source-derived draft.

experimental_model

Fetal rat lung explants; A549 cells studied separately; oxygen-dependent conditions and endpoints retained in source.

interpretation_status

Source-derived extraction of a fact-checked reference; access is explicit, not independent raw-data verification.

limitations

Interpret only within the recorded preparation, exposure and comparator. The complete source passage retains qualifications; unspecified doses/timing have not been extracted here. No clinical efficacy, nutrient deficiency or unique molecular mediation is inferred.

plain_language

Combined thymulin/zinc reduced TNF protein in the developmental lung experiments; transcript and protein effects must remain separate.

primary_references

Thymulin evokes IL-6-C/EBPbeta regenerative repair and TNF-alpha silencing during endotoxin exposure in fetal lung explants. | 2004 | DOI 10.1152/ajplung.00401.2002 | PMID 12639846 | https://doi.org/10.1152/ajplung.00401.2002

source_locator

Reviewed reference lines 70-70; exact primary location described in quoted passage where extracted.

Thymulin: detailed mechanisms of action (reviewed 3 October 2026) · lines 70–70

Original AI-assisted review of primary studies and, where relevant, official regulatory records. Access level is retained per claim. Corrections, null results and unresolved questions remain explicit. Not publisher full text or independent replication. · supports · Fetal rat lung explants; A549 cells studied separately; oxygen-dependent conditions and endpoints retained in source. · Recorded from source · Recorded from source

| Fetal rat lung explants and A549 lung cells, oxygen-dependent conditions | Combined thymulin/zinc exposure increased IL-6 and reduced TNF protein, with p38/MAPKAPK2 and transcription-factor responses. In explants, IL-6 antisense interfered with mesenchymal growth and FGF9-associated effects. | Increased IL-6 here is a developmental response; TNF transcript and protein need separate records. Joint peptide/zinc treatment cannot automatically be attributed to peptide alone. [2004 experiment](https://doi.org/10.1152/ajplung.00401.2002) |

evidence_access

Full text obtained; relevant results/methods inspected. This does not assert exhaustive figure/data reanalysis.

experimental_condition

Repeated-LPS control tested formulation · Thymulin Condition belongs to the full experimental contrast; do not separate a joint intervention.

experimental_contrast

{"intervention": "thymulin with repeated LPS", "comparator": "Repeated-LPS control", "endpoint": "In repeated-LPS mice, free thymulin reduced reported splenic jnk phosphorylation/signaling readouts.", "effect_direction": "decrease", "combination": "joint", "conditions": [{"entity_slug": "thymulin", "state": "tested formulation"}, {"entity_slug": null, "state": "repeated LPS"}]} Explicit extracted experimental comparison; source-derived draft.

experimental_model

Repeated-LPS mouse model; not human infectious sepsis. Free and nanoparticle formulations are separate.

interpretation_status

Source-derived extraction of a fact-checked reference; access is explicit, not independent raw-data verification.

limitations

Interpret only within the recorded preparation, exposure and comparator. The complete source passage retains qualifications; unspecified doses/timing have not been extracted here. No clinical efficacy, nutrient deficiency or unique molecular mediation is inferred.

plain_language

In repeated-LPS mice, free thymulin reduced reported splenic jnk phosphorylation/signaling readouts.

primary_references

Thymulin, free or bound to PBCA nanoparticles, protects mice against chronic septic inflammation | 2018 | DOI 10.1371/journal.pone.0197601 | PMID 29795607 | https://doi.org/10.1371/journal.pone.0197601

source_locator

Reviewed reference lines 71-71; exact primary location described in quoted passage where extracted.

Thymulin: detailed mechanisms of action (reviewed 3 October 2026) · lines 71–71

Original AI-assisted review of primary studies and, where relevant, official regulatory records. Access level is retained per claim. Corrections, null results and unresolved questions remain explicit. Not publisher full text or independent replication. · supports · Repeated-LPS mouse model; not human infectious sepsis. Free and nanoparticle formulations are separate. · Recorded from source · Recorded from source

| Mice receiving repeated LPS, free thymulin or PBCA-bound thymulin | Reduced splenic phosphorylation of IKK, p65, JNK, p38 and PKCθ was reported, with changes in stress proteins and apoptosis-related readouts. | Repeated endotoxin exposure is not the same as human infectious sepsis. Free peptide and nanoparticle formulations require separate exposure records. [2018 experiment](https://doi.org/10.1371/journal.pone.0197601) |

evidence_access

Full text obtained; relevant results/methods inspected. This does not assert exhaustive figure/data reanalysis.

experimental_condition

Repeated-LPS control tested formulation · Thymulin Condition belongs to the full experimental contrast; do not separate a joint intervention.

experimental_contrast

{"intervention": "thymulin with repeated LPS", "comparator": "Repeated-LPS control", "endpoint": "In repeated-LPS mice, free thymulin reduced reported splenic nfkb phosphorylation/signaling readouts.", "effect_direction": "decrease", "combination": "joint", "conditions": [{"entity_slug": "thymulin", "state": "tested formulation"}, {"entity_slug": null, "state": "repeated LPS"}]} Explicit extracted experimental comparison; source-derived draft.

experimental_model

Repeated-LPS mouse model; not human infectious sepsis. Free and nanoparticle formulations are separate.

interpretation_status

Source-derived extraction of a fact-checked reference; access is explicit, not independent raw-data verification.

limitations

Interpret only within the recorded preparation, exposure and comparator. The complete source passage retains qualifications; unspecified doses/timing have not been extracted here. No clinical efficacy, nutrient deficiency or unique molecular mediation is inferred.

plain_language

In repeated-LPS mice, free thymulin reduced reported splenic nfkb phosphorylation/signaling readouts.

primary_references

Thymulin, free or bound to PBCA nanoparticles, protects mice against chronic septic inflammation | 2018 | DOI 10.1371/journal.pone.0197601 | PMID 29795607 | https://doi.org/10.1371/journal.pone.0197601

source_locator

Reviewed reference lines 71-71; exact primary location described in quoted passage where extracted.

Thymulin: detailed mechanisms of action (reviewed 3 October 2026) · lines 71–71

Original AI-assisted review of primary studies and, where relevant, official regulatory records. Access level is retained per claim. Corrections, null results and unresolved questions remain explicit. Not publisher full text or independent replication. · supports · Repeated-LPS mouse model; not human infectious sepsis. Free and nanoparticle formulations are separate. · Recorded from source · Recorded from source

| Mice receiving repeated LPS, free thymulin or PBCA-bound thymulin | Reduced splenic phosphorylation of IKK, p65, JNK, p38 and PKCθ was reported, with changes in stress proteins and apoptosis-related readouts. | Repeated endotoxin exposure is not the same as human infectious sepsis. Free peptide and nanoparticle formulations require separate exposure records. [2018 experiment](https://doi.org/10.1371/journal.pone.0197601) |

evidence_access

Full text obtained; relevant results/methods inspected. This does not assert exhaustive figure/data reanalysis.

experimental_condition

Repeated-LPS control tested formulation · Thymulin Condition belongs to the full experimental contrast; do not separate a joint intervention.

experimental_contrast

{"intervention": "thymulin with repeated LPS", "comparator": "Repeated-LPS control", "endpoint": "In repeated-LPS mice, free thymulin reduced reported splenic p38 phosphorylation/signaling readouts.", "effect_direction": "decrease", "combination": "joint", "conditions": [{"entity_slug": "thymulin", "state": "tested formulation"}, {"entity_slug": null, "state": "repeated LPS"}]} Explicit extracted experimental comparison; source-derived draft.

experimental_model

Repeated-LPS mouse model; not human infectious sepsis. Free and nanoparticle formulations are separate.

interpretation_status

Source-derived extraction of a fact-checked reference; access is explicit, not independent raw-data verification.

limitations

Interpret only within the recorded preparation, exposure and comparator. The complete source passage retains qualifications; unspecified doses/timing have not been extracted here. No clinical efficacy, nutrient deficiency or unique molecular mediation is inferred.

plain_language

In repeated-LPS mice, free thymulin reduced reported splenic p38 phosphorylation/signaling readouts.

primary_references

Thymulin, free or bound to PBCA nanoparticles, protects mice against chronic septic inflammation | 2018 | DOI 10.1371/journal.pone.0197601 | PMID 29795607 | https://doi.org/10.1371/journal.pone.0197601

source_locator

Reviewed reference lines 71-71; exact primary location described in quoted passage where extracted.

Thymulin: detailed mechanisms of action (reviewed 3 October 2026) · lines 71–71

Original AI-assisted review of primary studies and, where relevant, official regulatory records. Access level is retained per claim. Corrections, null results and unresolved questions remain explicit. Not publisher full text or independent replication. · supports · Repeated-LPS mouse model; not human infectious sepsis. Free and nanoparticle formulations are separate. · Recorded from source · Recorded from source

| Mice receiving repeated LPS, free thymulin or PBCA-bound thymulin | Reduced splenic phosphorylation of IKK, p65, JNK, p38 and PKCθ was reported, with changes in stress proteins and apoptosis-related readouts. | Repeated endotoxin exposure is not the same as human infectious sepsis. Free peptide and nanoparticle formulations require separate exposure records. [2018 experiment](https://doi.org/10.1371/journal.pone.0197601) |

evidence_access

Primary bibliographic record and abstract checked; full methods/figures not comprehensively reviewed.

experimental_contrast

{"intervention": "Zinc-thymulin exposure", "comparator": "Study control", "endpoint": "Induction of IL-2-receptor-positive lymphocytes was used as a functional zinc-thymulin readout; it is not equivalent to IL-2 secretion.", "effect_direction": "increase", "combination": "single", "conditions": []} Explicit extracted experimental comparison; source-derived draft.

experimental_model

Human lymphocyte functional readout in TEC study.

interpretation_status

Source-derived extraction of a fact-checked reference; access is explicit, not independent raw-data verification.

limitations

Interpret only within the recorded preparation, exposure and comparator. The complete source passage retains qualifications; unspecified doses/timing have not been extracted here. No clinical efficacy, nutrient deficiency or unique molecular mediation is inferred.

plain_language

Induction of IL-2-receptor-positive lymphocytes was used as a functional zinc-thymulin readout; it is not equivalent to IL-2 secretion.

primary_references

Interleukin 1 regulates secretion of zinc-thymulin by human thymic epithelial cells and its action on T-lymphocyte proliferation and nuclear protein kinase C. | 1992 | DOI 10.1073/pnas.89.16.7752 | PMID 1502195 | https://doi.org/10.1073/pnas.89.16.7752

source_locator

Reviewed reference lines 56-56; exact primary location described in quoted passage where extracted.

Thymulin: detailed mechanisms of action (reviewed 3 October 2026) · lines 56–56

Original AI-assisted review of primary studies and, where relevant, official regulatory records. Access level is retained per claim. Corrections, null results and unresolved questions remain explicit. Not publisher full text or independent replication. · supports · Human lymphocyte functional readout in TEC study. · Recorded from source · Recorded from source

The human TEC study used induction of IL-2-receptor-positive lymphocytes as a functional readout. It also found that zinc–thymulin increased nuclear PKC activity in isolated lymphocyte nuclei **when IL-1 was present**, but not without IL-1. Keep the nuclear preparation, cytokine requirement and readout attached to that result. It does not establish an unconditional receptor → PKC → IL-2-production pathway in intact T cells. [Human-cell study](https://doi.org/10.1073/pnas.89.16.7752)

evidence_access

Primary bibliographic record and abstract checked; full methods/figures not comprehensively reviewed.

experimental_condition

Zinc-thymulin without IL-1 zinc-thymulin exposure · Thymulin Condition belongs to the full experimental contrast; do not separate a joint intervention.

experimental_contrast

{"intervention": "Zinc-thymulin with IL-1", "comparator": "Zinc-thymulin without IL-1", "endpoint": "Zinc-thymulin increased nuclear PKC activity in isolated lymphocyte nuclei when IL-1 was present, but not without IL-1.", "effect_direction": "mixed", "combination": "joint", "conditions": [{"entity_slug": "thymulin", "state": "zinc-thymulin exposure"}, {"entity_slug": null, "state": "IL-1 present"}]} Explicit extracted experimental comparison; source-derived draft.

experimental_model

Isolated human lymphocyte nuclei; cytokine-dependent effect, not unconditional intact-cell signaling.

interpretation_status

Source-derived extraction of a fact-checked reference; access is explicit, not independent raw-data verification.

limitations

Interpret only within the recorded preparation, exposure and comparator. The complete source passage retains qualifications; unspecified doses/timing have not been extracted here. No clinical efficacy, nutrient deficiency or unique molecular mediation is inferred.

plain_language

Zinc-thymulin increased nuclear PKC activity in isolated lymphocyte nuclei when IL-1 was present, but not without IL-1.

primary_references

Interleukin 1 regulates secretion of zinc-thymulin by human thymic epithelial cells and its action on T-lymphocyte proliferation and nuclear protein kinase C. | 1992 | DOI 10.1073/pnas.89.16.7752 | PMID 1502195 | https://doi.org/10.1073/pnas.89.16.7752

source_locator

Reviewed reference lines 56-56; exact primary location described in quoted passage where extracted.

Thymulin: detailed mechanisms of action (reviewed 3 October 2026) · lines 56–56

Original AI-assisted review of primary studies and, where relevant, official regulatory records. Access level is retained per claim. Corrections, null results and unresolved questions remain explicit. Not publisher full text or independent replication. · supports · Isolated human lymphocyte nuclei; cytokine-dependent effect, not unconditional intact-cell signaling. · Recorded from source · Recorded from source

The human TEC study used induction of IL-2-receptor-positive lymphocytes as a functional readout. It also found that zinc–thymulin increased nuclear PKC activity in isolated lymphocyte nuclei **when IL-1 was present**, but not without IL-1. Keep the nuclear preparation, cytokine requirement and readout attached to that result. It does not establish an unconditional receptor → PKC → IL-2-production pathway in intact T cells. [Human-cell study](https://doi.org/10.1073/pnas.89.16.7752)

evidence_access

Primary bibliographic record and abstract checked; full methods/figures not comprehensively reviewed.

experimental_contrast

{"intervention": "Picomolar zinc-thymulin", "comparator": "Matched tissue control", "endpoint": "Picomolar zinc-thymulin stimulated ACTH in isolated rat anterior-pituitary tissue with cAMP-associated changes.", "effect_direction": "increase", "combination": "single", "conditions": []} Explicit extracted experimental comparison; source-derived draft.

experimental_model

Isolated rat anterior-pituitary tissue; picomolar zinc-thymulin; concentration-dependent cAMP/cGMP responses. Not human cortisol measurement.

interpretation_status

Source-derived extraction of a fact-checked reference; access is explicit, not independent raw-data verification.

limitations

Interpret only within the recorded preparation, exposure and comparator. The complete source passage retains qualifications; unspecified doses/timing have not been extracted here. No clinical efficacy, nutrient deficiency or unique molecular mediation is inferred.

plain_language

Picomolar zinc-thymulin stimulated ACTH in isolated rat anterior-pituitary tissue with cAMP-associated changes.

primary_references

Thymulin stimulates corticotrophin release and cyclic nucleotide formation in the rat anterior pituitary gland. | 1997 | DOI 10.1159/000097322 | PMID 9483196 | https://pubmed.ncbi.nlm.nih.gov/9483196/

source_locator

Reviewed reference lines 104-104; exact primary location described in quoted passage where extracted.

Thymulin: detailed mechanisms of action (reviewed 3 October 2026) · lines 104–104

Original AI-assisted review of primary studies and, where relevant, official regulatory records. Access level is retained per claim. Corrections, null results and unresolved questions remain explicit. Not publisher full text or independent replication. · supports · Isolated rat anterior-pituitary tissue; picomolar zinc-thymulin; concentration-dependent cAMP/cGMP responses. Not human cortisol measurement. · Recorded from source · Recorded from source

In isolated rat anterior pituitary tissue, picomolar zinc–thymulin stimulated ACTH, accompanied by cAMP changes and cGMP changes at higher tested concentrations. A cAMP-directed phosphodiesterase inhibitor enhanced some responses, whereas the cGMP-directed inhibitor attenuated responses at higher concentrations. LH increased at selected concentrations, **GH did not**, and prolactin decreased. This does not establish human cortisol elevation or blood–brain barrier passage. [1997 study](https://pubmed.ncbi.nlm.nih.gov/9483196/)

evidence_access

Primary bibliographic record and abstract checked; full methods/figures not comprehensively reviewed.

experimental_contrast

{"intervention": "Picomolar zinc-thymulin", "comparator": "Matched tissue control", "endpoint": "GH did not increase in the picomolar zinc-thymulin isolated rat anterior-pituitary experiment.", "effect_direction": "no_detected_change", "combination": "single", "conditions": []} Explicit extracted experimental comparison; source-derived draft.

experimental_model

Isolated rat anterior-pituitary tissue; picomolar zinc-thymulin; concentration-dependent cAMP/cGMP responses. Not human cortisol measurement.

interpretation_status

Source-derived extraction of a fact-checked reference; access is explicit, not independent raw-data verification.

limitations

Interpret only within the recorded preparation, exposure and comparator. The complete source passage retains qualifications; unspecified doses/timing have not been extracted here. No clinical efficacy, nutrient deficiency or unique molecular mediation is inferred.

plain_language

GH did not increase in the picomolar zinc-thymulin isolated rat anterior-pituitary experiment.

primary_references

Thymulin stimulates corticotrophin release and cyclic nucleotide formation in the rat anterior pituitary gland. | 1997 | DOI 10.1159/000097322 | PMID 9483196 | https://pubmed.ncbi.nlm.nih.gov/9483196/

source_locator

Reviewed reference lines 104-104; exact primary location described in quoted passage where extracted.

Thymulin: detailed mechanisms of action (reviewed 3 October 2026) · lines 104–104

Original AI-assisted review of primary studies and, where relevant, official regulatory records. Access level is retained per claim. Corrections, null results and unresolved questions remain explicit. Not publisher full text or independent replication. · supports · Isolated rat anterior-pituitary tissue; picomolar zinc-thymulin; concentration-dependent cAMP/cGMP responses. Not human cortisol measurement. · Recorded from source · Recorded from source

In isolated rat anterior pituitary tissue, picomolar zinc–thymulin stimulated ACTH, accompanied by cAMP changes and cGMP changes at higher tested concentrations. A cAMP-directed phosphodiesterase inhibitor enhanced some responses, whereas the cGMP-directed inhibitor attenuated responses at higher concentrations. LH increased at selected concentrations, **GH did not**, and prolactin decreased. This does not establish human cortisol elevation or blood–brain barrier passage. [1997 study](https://pubmed.ncbi.nlm.nih.gov/9483196/)

evidence_access

Primary bibliographic record and abstract checked; full methods/figures not comprehensively reviewed.

experimental_contrast

{"intervention": "Thymulin", "comparator": "Matched cell preparation", "endpoint": "Higher-concentration thymulin stimulated GH release in dispersed rat pituitary preparations; responses depended on age and concentration.", "effect_direction": "increase", "combination": "single", "conditions": []} Explicit extracted experimental comparison; source-derived draft.

experimental_model

Dispersed rat pituitary cells; higher concentration than earlier tissue study; no universal GH sign.

interpretation_status

Source-derived extraction of a fact-checked reference; access is explicit, not independent raw-data verification.

limitations

Interpret only within the recorded preparation, exposure and comparator. The complete source passage retains qualifications; unspecified doses/timing have not been extracted here. No clinical efficacy, nutrient deficiency or unique molecular mediation is inferred.

plain_language

Higher-concentration thymulin stimulated GH release in dispersed rat pituitary preparations; responses depended on age and concentration.

primary_references

Growth hormone-releasing activity of thymulin on pituitary somatotropes is age dependent. | 1999 | DOI 10.1159/000054399 | PMID 9892847 | https://pubmed.ncbi.nlm.nih.gov/9892847/

source_locator

Reviewed reference lines 106-106; exact primary location described in quoted passage where extracted.

Thymulin: detailed mechanisms of action (reviewed 3 October 2026) · lines 106–106

Original AI-assisted review of primary studies and, where relevant, official regulatory records. Access level is retained per claim. Corrections, null results and unresolved questions remain explicit. Not publisher full text or independent replication. · supports · Dispersed rat pituitary cells; higher concentration than earlier tissue study; no universal GH sign. · Recorded from source · Recorded from source

In a different dispersed-rat-pituitary study using higher concentrations, thymulin stimulated **GH** release; responses depended on age and concentration. EGTA blocked activity, and cAMP enhancers potentiated it. These interventions support calcium-sensitive signaling, not a requirement for calcium bound directly to thymulin. The earlier GH null remains part of the evidence. [1999 GH study](https://pubmed.ncbi.nlm.nih.gov/9892847/)

evidence_access

Primary bibliographic record and abstract checked; full methods/figures not comprehensively reviewed.

experimental_contrast

{"intervention": "Picomolar zinc-thymulin", "comparator": "Matched tissue control", "endpoint": "Prolactin decreased in the picomolar zinc-thymulin isolated rat anterior-pituitary experiment.", "effect_direction": "decrease", "combination": "single", "conditions": []} Explicit extracted experimental comparison; source-derived draft.

experimental_model

Isolated rat anterior-pituitary tissue; picomolar zinc-thymulin; concentration-dependent cAMP/cGMP responses. Not human cortisol measurement.

interpretation_status

Source-derived extraction of a fact-checked reference; access is explicit, not independent raw-data verification.

limitations

Interpret only within the recorded preparation, exposure and comparator. The complete source passage retains qualifications; unspecified doses/timing have not been extracted here. No clinical efficacy, nutrient deficiency or unique molecular mediation is inferred.

plain_language

Prolactin decreased in the picomolar zinc-thymulin isolated rat anterior-pituitary experiment.

primary_references

Thymulin stimulates corticotrophin release and cyclic nucleotide formation in the rat anterior pituitary gland. | 1997 | DOI 10.1159/000097322 | PMID 9483196 | https://pubmed.ncbi.nlm.nih.gov/9483196/

source_locator

Reviewed reference lines 104-104; exact primary location described in quoted passage where extracted.

Thymulin: detailed mechanisms of action (reviewed 3 October 2026) · lines 104–104

Original AI-assisted review of primary studies and, where relevant, official regulatory records. Access level is retained per claim. Corrections, null results and unresolved questions remain explicit. Not publisher full text or independent replication. · supports · Isolated rat anterior-pituitary tissue; picomolar zinc-thymulin; concentration-dependent cAMP/cGMP responses. Not human cortisol measurement. · Recorded from source · Recorded from source

In isolated rat anterior pituitary tissue, picomolar zinc–thymulin stimulated ACTH, accompanied by cAMP changes and cGMP changes at higher tested concentrations. A cAMP-directed phosphodiesterase inhibitor enhanced some responses, whereas the cGMP-directed inhibitor attenuated responses at higher concentrations. LH increased at selected concentrations, **GH did not**, and prolactin decreased. This does not establish human cortisol elevation or blood–brain barrier passage. [1997 study](https://pubmed.ncbi.nlm.nih.gov/9483196/)

evidence_access

Primary bibliographic record and abstract checked; full methods/figures not comprehensively reviewed.

experimental_contrast

{"intervention": "Thymulin", "comparator": "Matched pituitary preparation", "endpoint": "Thymulin increased prolactin release in a separate rat pituitary experiment, with a bell-shaped response and weaker effects in senescent preparations.", "effect_direction": "increase", "combination": "single", "conditions": []} Explicit extracted experimental comparison; source-derived draft.

experimental_model

Rat pituitary incubation study; concentration/age dependence, not demonstrated binding to the TRH receptor.

interpretation_status

Source-derived extraction of a fact-checked reference; access is explicit, not independent raw-data verification.

limitations

Interpret only within the recorded preparation, exposure and comparator. The complete source passage retains qualifications; unspecified doses/timing have not been extracted here. No clinical efficacy, nutrient deficiency or unique molecular mediation is inferred.

plain_language

Thymulin increased prolactin release in a separate rat pituitary experiment, with a bell-shaped response and weaker effects in senescent preparations.

primary_references

Thymulin stimulates prolactin and thyrotropin release in an age-related manner. | 1998 | DOI 10.1016/s0047-6374(98)00072-4 | PMID 9818729 | https://pubmed.ncbi.nlm.nih.gov/9818729/

source_locator

Reviewed reference lines 108-108; exact primary location described in quoted passage where extracted.

Thymulin: detailed mechanisms of action (reviewed 3 October 2026) · lines 108–108

Original AI-assisted review of primary studies and, where relevant, official regulatory records. Access level is retained per claim. Corrections, null results and unresolved questions remain explicit. Not publisher full text or independent replication. · supports · Rat pituitary incubation study; concentration/age dependence, not demonstrated binding to the TRH receptor. · Recorded from source · Recorded from source

Likewise, a separate study found **prolactin and TSH increases**, with a bell-shaped concentration response in incubation experiments, potentiation by TRH and cAMP-associated interventions, and weaker responses in senescent preparations. EGTA blocked release. The opposite prolactin directions across studies are an unresolved comparison involving concentration and preparation, not grounds to discard either result. TRH-like behavior does not establish binding to the TRH receptor. [1998 prolactin/TSH study](https://pubmed.ncbi.nlm.nih.gov/9818729/)

evidence_access

Primary bibliographic record and abstract checked; full methods/figures not comprehensively reviewed.

experimental_contrast

{"intervention": "Thymulin", "comparator": "Matched pituitary preparation", "endpoint": "Thymulin increased TSH release in a separate rat pituitary experiment; TRH and cAMP-associated interventions potentiated responses and EGTA blocked release.", "effect_direction": "increase", "combination": "single", "conditions": []} Explicit extracted experimental comparison; source-derived draft.

experimental_model

Rat pituitary incubation study; concentration/age dependence, not demonstrated binding to the TRH receptor.

interpretation_status

Source-derived extraction of a fact-checked reference; access is explicit, not independent raw-data verification.

limitations

Interpret only within the recorded preparation, exposure and comparator. The complete source passage retains qualifications; unspecified doses/timing have not been extracted here. No clinical efficacy, nutrient deficiency or unique molecular mediation is inferred.

plain_language

Thymulin increased TSH release in a separate rat pituitary experiment; TRH and cAMP-associated interventions potentiated responses and EGTA blocked release.

primary_references

Thymulin stimulates prolactin and thyrotropin release in an age-related manner. | 1998 | DOI 10.1016/s0047-6374(98)00072-4 | PMID 9818729 | https://pubmed.ncbi.nlm.nih.gov/9818729/

source_locator

Reviewed reference lines 108-108; exact primary location described in quoted passage where extracted.

Thymulin: detailed mechanisms of action (reviewed 3 October 2026) · lines 108–108

Original AI-assisted review of primary studies and, where relevant, official regulatory records. Access level is retained per claim. Corrections, null results and unresolved questions remain explicit. Not publisher full text or independent replication. · supports · Rat pituitary incubation study; concentration/age dependence, not demonstrated binding to the TRH receptor. · Recorded from source · Recorded from source

Likewise, a separate study found **prolactin and TSH increases**, with a bell-shaped concentration response in incubation experiments, potentiation by TRH and cAMP-associated interventions, and weaker responses in senescent preparations. EGTA blocked release. The opposite prolactin directions across studies are an unresolved comparison involving concentration and preparation, not grounds to discard either result. TRH-like behavior does not establish binding to the TRH receptor. [1998 prolactin/TSH study](https://pubmed.ncbi.nlm.nih.gov/9818729/)

evidence_access

Primary bibliographic record and abstract checked; full methods/figures not comprehensively reviewed.

experimental_contrast

{"intervention": "Thymulin exposure", "comparator": "Study control", "endpoint": "Thymulin increased HSP72 in the macrophage experiment.", "effect_direction": "increase", "combination": "single", "conditions": []} Explicit extracted experimental comparison; source-derived draft.

experimental_model

Mouse RAW264.7 macrophages; protein readout.

interpretation_status

Source-derived extraction of a fact-checked reference; access is explicit, not independent raw-data verification.

limitations

Interpret only within the recorded preparation, exposure and comparator. The complete source passage retains qualifications; unspecified doses/timing have not been extracted here. No clinical efficacy, nutrient deficiency or unique molecular mediation is inferred.

plain_language

Thymulin increased HSP72 in the macrophage experiment.

primary_references

Thymus peptides regulate activity of RAW 264.7 macrophage cells: inhibitory analysis and a role of signal cascades. | 2011 | DOI 10.1517/14728222.2011.641952 | PMID 22148922 | https://pubmed.ncbi.nlm.nih.gov/22148922/

source_locator

Reviewed reference lines 68-68; exact primary location described in quoted passage where extracted.

Thymulin: detailed mechanisms of action (reviewed 3 October 2026) · lines 68–68

Original AI-assisted review of primary studies and, where relevant, official regulatory records. Access level is retained per claim. Corrections, null results and unresolved questions remain explicit. Not publisher full text or independent replication. · supports · Mouse RAW264.7 macrophages; protein readout. · Recorded from source · Recorded from source

| RAW264.7 macrophages, unstimulated versus LPS-stimulated | In resting cells, thymulin increased proinflammatory cytokine secretion. In LPS-stimulated cells, it reduced SAPK/JNK activity but not NF-κB activity; peptide alone did not change the measured cytokine secretion. HSP72 increased. | Preserve the resting/stimulated contrast. Thymopentin was also studied and requires separate attribution. [2011 experiment](https://pubmed.ncbi.nlm.nih.gov/22148922/) |

evidence_access

Primary bibliographic record and abstract checked; full methods/figures not comprehensively reviewed.

experimental_condition

LPS alone added peptide · Thymulin Condition belongs to the full experimental contrast; do not separate a joint intervention.

experimental_contrast

{"intervention": "Thymulin plus LPS", "comparator": "LPS alone", "endpoint": "Thymulin reduced SAPK/JNK activity in LPS-stimulated RAW264.7 cells.", "effect_direction": "decrease", "combination": "joint", "conditions": [{"entity_slug": "thymulin", "state": "added peptide"}, {"entity_slug": null, "state": "LPS stimulation"}]} Explicit extracted experimental comparison; source-derived draft.

experimental_model

Mouse RAW264.7 macrophages stimulated with LPS; isoform unresolved.

interpretation_status

Source-derived extraction of a fact-checked reference; access is explicit, not independent raw-data verification.

limitations

Interpret only within the recorded preparation, exposure and comparator. The complete source passage retains qualifications; unspecified doses/timing have not been extracted here. No clinical efficacy, nutrient deficiency or unique molecular mediation is inferred.

plain_language

Thymulin reduced SAPK/JNK activity in LPS-stimulated RAW264.7 cells.

primary_references

Thymus peptides regulate activity of RAW 264.7 macrophage cells: inhibitory analysis and a role of signal cascades. | 2011 | DOI 10.1517/14728222.2011.641952 | PMID 22148922 | https://pubmed.ncbi.nlm.nih.gov/22148922/

source_locator

Reviewed reference lines 68-68; exact primary location described in quoted passage where extracted.

Thymulin: detailed mechanisms of action (reviewed 3 October 2026) · lines 68–68

Original AI-assisted review of primary studies and, where relevant, official regulatory records. Access level is retained per claim. Corrections, null results and unresolved questions remain explicit. Not publisher full text or independent replication. · supports · Mouse RAW264.7 macrophages stimulated with LPS; isoform unresolved. · Recorded from source · Recorded from source

| RAW264.7 macrophages, unstimulated versus LPS-stimulated | In resting cells, thymulin increased proinflammatory cytokine secretion. In LPS-stimulated cells, it reduced SAPK/JNK activity but not NF-κB activity; peptide alone did not change the measured cytokine secretion. HSP72 increased. | Preserve the resting/stimulated contrast. Thymopentin was also studied and requires separate attribution. [2011 experiment](https://pubmed.ncbi.nlm.nih.gov/22148922/) |

evidence_access

Primary bibliographic record and abstract checked; full methods/figures not comprehensively reviewed.

experimental_condition

LPS alone added peptide · Thymulin Condition belongs to the full experimental contrast; do not separate a joint intervention.

experimental_contrast

{"intervention": "Thymulin plus LPS", "comparator": "LPS alone", "endpoint": "Thymulin did not reduce the reported NF-kappa-B activation readout in LPS-stimulated RAW264.7 macrophages; this is not evidence for unconditional NF-kappa-B inhibition.", "effect_direction": "no_detected_change", "combination": "joint", "conditions": [{"entity_slug": "thymulin", "state": "added peptide"}, {"entity_slug": null, "state": "LPS stimulation"}]} Explicit extracted experimental comparison; source-derived draft.

experimental_model

Mouse RAW264.7 macrophages; LPS stimulation; endpoint retained at reported pathway level.

interpretation_status

Source-derived extraction of a fact-checked reference; access is explicit, not independent raw-data verification.

limitations

Interpret only within the recorded preparation, exposure and comparator. The complete source passage retains qualifications; unspecified doses/timing have not been extracted here. No clinical efficacy, nutrient deficiency or unique molecular mediation is inferred.

plain_language

Thymulin did not reduce the reported NF-kappa-B activation readout in LPS-stimulated RAW264.7 macrophages; this is not evidence for unconditional NF-kappa-B inhibition.

primary_references

Thymus peptides regulate activity of RAW 264.7 macrophage cells: inhibitory analysis and a role of signal cascades. | 2011 | DOI 10.1517/14728222.2011.641952 | PMID 22148922 | https://pubmed.ncbi.nlm.nih.gov/22148922/

source_locator

Reviewed reference lines 68-68; exact primary location described in quoted passage where extracted.

Thymulin: detailed mechanisms of action (reviewed 3 October 2026) · lines 68–68

Original AI-assisted review of primary studies and, where relevant, official regulatory records. Access level is retained per claim. Corrections, null results and unresolved questions remain explicit. Not publisher full text or independent replication. · supports · Mouse RAW264.7 macrophages; LPS stimulation; endpoint retained at reported pathway level. · Recorded from source · Recorded from source

| RAW264.7 macrophages, unstimulated versus LPS-stimulated | In resting cells, thymulin increased proinflammatory cytokine secretion. In LPS-stimulated cells, it reduced SAPK/JNK activity but not NF-κB activity; peptide alone did not change the measured cytokine secretion. HSP72 increased. | Preserve the resting/stimulated contrast. Thymopentin was also studied and requires separate attribution. [2011 experiment](https://pubmed.ncbi.nlm.nih.gov/22148922/) |

evidence_access

Primary bibliographic record and abstract checked; full methods/figures not comprehensively reviewed.

experimental_contrast

{"intervention": "Thymulin with or without LPS", "comparator": "Matched stimulus-only/untreated controls", "endpoint": "Thymulin increased proinflammatory cytokine secretion in unstimulated RAW264.7 macrophages. In LPS-stimulated cells, thymulin alone did not change the measured cytokine secretion.", "effect_direction": "mixed", "combination": "single", "conditions": []} Explicit extracted experimental comparison; source-derived draft.

experimental_model

Mouse RAW264.7 macrophages; resting versus LPS stimulation.

interpretation_status

Source-derived extraction of a fact-checked reference; access is explicit, not independent raw-data verification.

limitations

Interpret only within the recorded preparation, exposure and comparator. The complete source passage retains qualifications; unspecified doses/timing have not been extracted here. No clinical efficacy, nutrient deficiency or unique molecular mediation is inferred.

plain_language

Thymulin increased proinflammatory cytokine secretion in unstimulated RAW264.7 macrophages. In LPS-stimulated cells, thymulin alone did not change the measured cytokine secretion.

primary_references

Thymus peptides regulate activity of RAW 264.7 macrophage cells: inhibitory analysis and a role of signal cascades. | 2011 | DOI 10.1517/14728222.2011.641952 | PMID 22148922 | https://pubmed.ncbi.nlm.nih.gov/22148922/

source_locator

Reviewed reference lines 68-68; exact primary location described in quoted passage where extracted.

Thymulin: detailed mechanisms of action (reviewed 3 October 2026) · lines 68–68

Original AI-assisted review of primary studies and, where relevant, official regulatory records. Access level is retained per claim. Corrections, null results and unresolved questions remain explicit. Not publisher full text or independent replication. · supports · Mouse RAW264.7 macrophages; resting versus LPS stimulation. · Recorded from source · Recorded from source

| RAW264.7 macrophages, unstimulated versus LPS-stimulated | In resting cells, thymulin increased proinflammatory cytokine secretion. In LPS-stimulated cells, it reduced SAPK/JNK activity but not NF-κB activity; peptide alone did not change the measured cytokine secretion. HSP72 increased. | Preserve the resting/stimulated contrast. Thymopentin was also studied and requires separate attribution. [2011 experiment](https://pubmed.ncbi.nlm.nih.gov/22148922/) |

evidence_access

Primary bibliographic record and abstract checked; full methods/figures not comprehensively reviewed.

experimental_model

Purified complexes in DMSO-d6; not serum or intracellular occupancy.

interpretation_status

Source-derived extraction of a fact-checked reference; access is explicit, not independent raw-data verification.

limitations

Interpret only within the recorded preparation, exposure and comparator. The complete source passage retains qualifications; unspecified doses/timing have not been extracted here. No clinical efficacy, nutrient deficiency or unique molecular mediation is inferred.

plain_language

NMR in DMSO-d6 identified 1:1 and 1:2 zinc-peptide complexes; Ser4 and the Asn9 terminal carboxylate coordinated zinc, with Ser8 participating in the 1:1 complex.

primary_references

NMR study of a lymphocyte differentiating thymic factor. An investigation of the Zn(II)-nonapeptide complexes (thymulin). | 1988 | DOI 10.1016/s0021-9258(18)60603-9 | PMID 3356698 | https://pubmed.ncbi.nlm.nih.gov/3356698/

source_locator

Reviewed reference lines 27-27; exact primary location described in quoted passage where extracted.

Thymulin: detailed mechanisms of action (reviewed 3 October 2026) · lines 27–27

Original AI-assisted review of primary studies and, where relevant, official regulatory records. Access level is retained per claim. Corrections, null results and unresolved questions remain explicit. Not publisher full text or independent replication. · supports · Purified complexes in DMSO-d6; not serum or intracellular occupancy. · Recorded from source · Recorded from source

The structural qualification matters: the 1988 NMR work was performed in **DMSO-d₆**, not blood. It identified 1:1 and 1:2 zinc–peptide complexes depending on the mixture. Coordination involved Ser4 and the Asn9 **terminal carboxylate**, with Ser8 also participating in the 1:1 complex. This supports a metal-dependent conformation but does not establish the distribution of complexes in living tissues. “One zinc per active peptide” should therefore describe a conventional preparation/activation model, not proven universal physiological occupancy. [NMR study](https://pubmed.ncbi.nlm.nih.gov/3356698/)

evidence_access

Primary bibliographic record and abstract checked; full methods/figures not comprehensively reviewed.

experimental_contrast

{"intervention": "growth-hormone exposure", "comparator": "Matched experimental control", "endpoint": "GH stimulated thymulin production in TEC preparations; IGF-I or IGF-I-receptor blockade inhibited the GH response.", "effect_direction": "increase", "combination": "single", "conditions": []} Explicit extracted experimental comparison; source-derived draft.

experimental_model

Preparations and species as specified in statement and source; no direct iodine/selenium cofactor requirement inferred.

interpretation_status

Source-derived extraction of a fact-checked reference; access is explicit, not independent raw-data verification.

limitations

Interpret only within the recorded preparation, exposure and comparator. The complete source passage retains qualifications; unspecified doses/timing have not been extracted here. No clinical efficacy, nutrient deficiency or unique molecular mediation is inferred.

plain_language

GH stimulated thymulin production in TEC preparations; IGF-I or IGF-I-receptor blockade inhibited the GH response.

primary_references

Growth hormone and insulin-like growth factor-I stimulate hormonal function and proliferation of thymic epithelial cells. | 1992 | DOI 10.1210/jcem.75.1.1619008 | PMID 1619008 | https://pubmed.ncbi.nlm.nih.gov/1619008/

source_locator

Reviewed reference lines 93-93; exact primary location described in quoted passage where extracted.

Thymulin: detailed mechanisms of action (reviewed 3 October 2026) · lines 93–93

Original AI-assisted review of primary studies and, where relevant, official regulatory records. Access level is retained per claim. Corrections, null results and unresolved questions remain explicit. Not publisher full text or independent replication. · supports · Preparations and species as specified in statement and source; no direct iodine/selenium cofactor requirement inferred. · Recorded from source · Recorded from source

| GH and IGF-I | Both stimulated production in TEC preparations. Blocking IGF-I or its receptor inhibited the GH response, supporting a local IGF-mediated component. The associated human endocrine observations do not isolate that mechanism in vivo. [1992 study](https://pubmed.ncbi.nlm.nih.gov/1619008/) |

evidence_access

Primary bibliographic record and abstract checked; full methods/figures not comprehensively reviewed.

experimental_contrast

{"intervention": "igf1 exposure", "comparator": "Matched experimental control", "endpoint": "IGF-I stimulated thymulin production in TEC preparations.", "effect_direction": "increase", "combination": "single", "conditions": []} Explicit extracted experimental comparison; source-derived draft.

experimental_model

Preparations and species as specified in statement and source; no direct iodine/selenium cofactor requirement inferred.

interpretation_status

Source-derived extraction of a fact-checked reference; access is explicit, not independent raw-data verification.

limitations

Interpret only within the recorded preparation, exposure and comparator. The complete source passage retains qualifications; unspecified doses/timing have not been extracted here. No clinical efficacy, nutrient deficiency or unique molecular mediation is inferred.

plain_language

IGF-I stimulated thymulin production in TEC preparations.

primary_references

Growth hormone and insulin-like growth factor-I stimulate hormonal function and proliferation of thymic epithelial cells. | 1992 | DOI 10.1210/jcem.75.1.1619008 | PMID 1619008 | https://pubmed.ncbi.nlm.nih.gov/1619008/

source_locator

Reviewed reference lines 93-93; exact primary location described in quoted passage where extracted.

Thymulin: detailed mechanisms of action (reviewed 3 October 2026) · lines 93–93

Original AI-assisted review of primary studies and, where relevant, official regulatory records. Access level is retained per claim. Corrections, null results and unresolved questions remain explicit. Not publisher full text or independent replication. · supports · Preparations and species as specified in statement and source; no direct iodine/selenium cofactor requirement inferred. · Recorded from source · Recorded from source

| GH and IGF-I | Both stimulated production in TEC preparations. Blocking IGF-I or its receptor inhibited the GH response, supporting a local IGF-mediated component. The associated human endocrine observations do not isolate that mechanism in vivo. [1992 study](https://pubmed.ncbi.nlm.nih.gov/1619008/) |

evidence_access

Primary bibliographic record and abstract checked; full methods/figures not comprehensively reviewed.

experimental_contrast

{"intervention": "prolactin exposure", "comparator": "Matched experimental control", "endpoint": "Prolactin increased thymulin secretion in human/mouse TEC cultures and thymulin activity in mice.", "effect_direction": "increase", "combination": "single", "conditions": []} Explicit extracted experimental comparison; source-derived draft.

experimental_model

Preparations and species as specified in statement and source; no direct iodine/selenium cofactor requirement inferred.

interpretation_status

Source-derived extraction of a fact-checked reference; access is explicit, not independent raw-data verification.

limitations

Interpret only within the recorded preparation, exposure and comparator. The complete source passage retains qualifications; unspecified doses/timing have not been extracted here. No clinical efficacy, nutrient deficiency or unique molecular mediation is inferred.

plain_language

Prolactin increased thymulin secretion in human/mouse TEC cultures and thymulin activity in mice.

primary_references

Neuroendocrine control of thymic hormonal production. I. Prolactin stimulates in vivo and in vitro the production of thymulin by human and murine thymic epithelial cells. | 1989 | DOI 10.1210/endo-125-1-3 | PMID 2737149 | https://pubmed.ncbi.nlm.nih.gov/2737149/

source_locator

Reviewed reference lines 92-92; exact primary location described in quoted passage where extracted.

Thymulin: detailed mechanisms of action (reviewed 3 October 2026) · lines 92–92

Original AI-assisted review of primary studies and, where relevant, official regulatory records. Access level is retained per claim. Corrections, null results and unresolved questions remain explicit. Not publisher full text or independent replication. · supports · Preparations and species as specified in statement and source; no direct iodine/selenium cofactor requirement inferred. · Recorded from source · Recorded from source

| Prolactin | Increased thymulin secretion in human/mouse TEC cultures. In mice, prolactin increased activity; bromocriptine lowered it, and concurrent prolactin restored it. This is an experimental hormone/drug interaction, not proof that every bromocriptine-treated person develops thymulin deficiency. [1989 study](https://pubmed.ncbi.nlm.nih.gov/2737149/) |

evidence_access

Primary bibliographic record and abstract checked; full methods/figures not comprehensively reviewed.

experimental_contrast

{"intervention": "triiodothyronine exposure", "comparator": "Matched experimental control", "endpoint": "T3 restored or stimulated thymulin production in mouse whole-thymus cultures, including a propylthiouracil-associated hypothyroid model; cycloheximide inhibited the response.", "effect_direction": "increase", "combination": "single", "conditions": []} Explicit extracted experimental comparison; source-derived draft.

experimental_model

Preparations and species as specified in statement and source; no direct iodine/selenium cofactor requirement inferred.

interpretation_status

Source-derived extraction of a fact-checked reference; access is explicit, not independent raw-data verification.

limitations

Interpret only within the recorded preparation, exposure and comparator. The complete source passage retains qualifications; unspecified doses/timing have not been extracted here. No clinical efficacy, nutrient deficiency or unique molecular mediation is inferred.

plain_language

T3 restored or stimulated thymulin production in mouse whole-thymus cultures, including a propylthiouracil-associated hypothyroid model; cycloheximide inhibited the response.

primary_references

Neuroendocrine-thymus interactions. I. In vitro modulation of thymic factor secretion by thyroid hormones. | 1990 | DOI 10.1007/bf03349524 | PMID 2184190 | https://pubmed.ncbi.nlm.nih.gov/2184190/

source_locator

Reviewed reference lines 94-94; exact primary location described in quoted passage where extracted.

Thymulin: detailed mechanisms of action (reviewed 3 October 2026) · lines 94–94

Original AI-assisted review of primary studies and, where relevant, official regulatory records. Access level is retained per claim. Corrections, null results and unresolved questions remain explicit. Not publisher full text or independent replication. · supports · Preparations and species as specified in statement and source; no direct iodine/selenium cofactor requirement inferred. · Recorded from source · Recorded from source

| Thyroid hormone | T3 restored/stimulated thymulin production in mouse whole-thymus cultures, including a propylthiouracil-associated hypothyroid model; inhibition by cycloheximide implicated new protein synthesis. This does not identify the peptide precursor. [1990 study](https://pubmed.ncbi.nlm.nih.gov/2184190/) |

evidence_access

Primary bibliographic record and abstract checked; full methods/figures not comprehensively reviewed.

experimental_model

Thymic epithelial cells and metal-sensitive antibody assays.

interpretation_status

Source-derived extraction of a fact-checked reference; access is explicit, not independent raw-data verification.

limitations

Interpret only within the recorded preparation, exposure and comparator. The complete source passage retains qualifications; unspecified doses/timing have not been extracted here. No clinical efficacy, nutrient deficiency or unique molecular mediation is inferred.

plain_language

Thymic epithelial cells produce thymulin; metal-dependent antibody recognition must be distinguished from peptide quantity and biological activity.

primary_references

A zinc-dependent epitope on the molecule of thymulin, a thymic hormone. | 1985 | DOI 10.1073/pnas.82.20.7035 | PMID 2413455 | https://doi.org/10.1073/pnas.82.20.7035

source_locator

Reviewed reference lines 33-33; exact primary location described in quoted passage where extracted.

Thymulin: detailed mechanisms of action (reviewed 3 October 2026) · lines 33–33

Original AI-assisted review of primary studies and, where relevant, official regulatory records. Access level is retained per claim. Corrections, null results and unresolved questions remain explicit. Not publisher full text or independent replication. · supports · Thymic epithelial cells and metal-sensitive antibody assays. · Recorded from source · Recorded from source

Thymic epithelial cells (TECs) are the established source. Production, secretion and metal-dependent activity should be represented as distinct processes. Antibody recognition of thymulin in TECs and serum also depends on the assay's sensitivity to metal-associated conformation. [TEC and antibody study](https://doi.org/10.1073/pnas.82.20.7035)

evidence_access

Primary bibliographic record and abstract checked; full methods/figures not comprehensively reviewed.

experimental_model

Engineered synthetic expression study.

interpretation_status

Source-derived extraction of a fact-checked reference; access is explicit, not independent raw-data verification.

limitations

Interpret only within the recorded preparation, exposure and comparator. The complete source passage retains qualifications; unspecified doses/timing have not been extracted here. No clinical efficacy, nutrient deficiency or unique molecular mediation is inferred.

plain_language

Experimental met-FTS gene delivery expresses an engineered analogue; it does not identify the native human FTS precursor gene.

primary_references

Gene therapy for long-term restoration of circulating thymulin in thymectomized mice and rats. | 2006 | DOI 10.1038/sj.gt.3302775 | PMID 16617301 | https://doi.org/10.1038/sj.gt.3302775

source_locator

Reviewed reference lines 50-50; exact primary location described in quoted passage where extracted.

Thymulin: detailed mechanisms of action (reviewed 3 October 2026) · lines 50–50

Original AI-assisted review of primary studies and, where relevant, official regulatory records. Access level is retained per claim. Corrections, null results and unresolved questions remain explicit. Not publisher full text or independent replication. · supports · Engineered synthetic expression study. · Recorded from source · Recorded from source

Identification of the peptide does not identify its full native biosynthetic pathway. No sufficiently established endogenous precursor gene and processing sequence was verified in this review. The synthetic **met-FTS** construct used for experimental gene delivery is an engineered analogue; successful expression is not discovery of the native human gene. [Synthetic expression study](https://doi.org/10.1038/sj.gt.3302775)

evidence_access

Primary bibliographic record and abstract checked; full methods/figures not comprehensively reviewed.

experimental_contrast

{"intervention": "IL-1 exposure", "comparator": "Untreated cultures", "endpoint": "IL-1 alpha and IL-1 beta increased secretion of biologically active thymulin from cultured human TECs.", "effect_direction": "increase", "combination": "single", "conditions": []} Explicit extracted experimental comparison; source-derived draft.

experimental_model

Cultured human TECs; bioactivity readout, not native precursor-gene discovery.

interpretation_status

Source-derived extraction of a fact-checked reference; access is explicit, not independent raw-data verification.

limitations

Interpret only within the recorded preparation, exposure and comparator. The complete source passage retains qualifications; unspecified doses/timing have not been extracted here. No clinical efficacy, nutrient deficiency or unique molecular mediation is inferred.

plain_language

IL-1 alpha and IL-1 beta increased secretion of biologically active thymulin from cultured human TECs.

primary_references

Interleukin 1 regulates secretion of zinc-thymulin by human thymic epithelial cells and its action on T-lymphocyte proliferation and nuclear protein kinase C. | 1992 | DOI 10.1073/pnas.89.16.7752 | PMID 1502195 | https://doi.org/10.1073/pnas.89.16.7752

source_locator

Reviewed reference lines 35-35; exact primary location described in quoted passage where extracted.

Thymulin: detailed mechanisms of action (reviewed 3 October 2026) · lines 35–35

Original AI-assisted review of primary studies and, where relevant, official regulatory records. Access level is retained per claim. Corrections, null results and unresolved questions remain explicit. Not publisher full text or independent replication. · supports · Cultured human TECs; bioactivity readout, not native precursor-gene discovery. · Recorded from source · Recorded from source

In cultured human TECs, **IL-1α and IL-1β increased zinc uptake, metallothionein mRNA and secretion of biologically active thymulin**. Part of the IL-1 effect on zinc uptake occurred independently of proliferation. Metallothionein was proposed as an intracellular zinc donor; direct transfer from a defined metallothionein molecule to FTS was not resolved by these observations. Do not turn that proposal into an established transfer reaction. [Coto et al., 1992](https://doi.org/10.1073/pnas.89.16.7752)

evidence_access

Primary bibliographic record and abstract checked; full methods/figures not comprehensively reviewed.

experimental_contrast

{"intervention": "IL-1 exposure", "comparator": "Untreated cultures", "endpoint": "IL-1 alpha and IL-1 beta increased secretion of biologically active thymulin from cultured human TECs.", "effect_direction": "increase", "combination": "single", "conditions": []} Explicit extracted experimental comparison; source-derived draft.

experimental_model

Cultured human TECs; bioactivity readout, not native precursor-gene discovery.

interpretation_status

Source-derived extraction of a fact-checked reference; access is explicit, not independent raw-data verification.

limitations

Interpret only within the recorded preparation, exposure and comparator. The complete source passage retains qualifications; unspecified doses/timing have not been extracted here. No clinical efficacy, nutrient deficiency or unique molecular mediation is inferred.

plain_language

IL-1 alpha and IL-1 beta increased secretion of biologically active thymulin from cultured human TECs.

primary_references

Interleukin 1 regulates secretion of zinc-thymulin by human thymic epithelial cells and its action on T-lymphocyte proliferation and nuclear protein kinase C. | 1992 | DOI 10.1073/pnas.89.16.7752 | PMID 1502195 | https://doi.org/10.1073/pnas.89.16.7752

source_locator

Reviewed reference lines 35-35; exact primary location described in quoted passage where extracted.

Thymulin: detailed mechanisms of action (reviewed 3 October 2026) · lines 35–35

Original AI-assisted review of primary studies and, where relevant, official regulatory records. Access level is retained per claim. Corrections, null results and unresolved questions remain explicit. Not publisher full text or independent replication. · supports · Cultured human TECs; bioactivity readout, not native precursor-gene discovery. · Recorded from source · Recorded from source

In cultured human TECs, **IL-1α and IL-1β increased zinc uptake, metallothionein mRNA and secretion of biologically active thymulin**. Part of the IL-1 effect on zinc uptake occurred independently of proliferation. Metallothionein was proposed as an intracellular zinc donor; direct transfer from a defined metallothionein molecule to FTS was not resolved by these observations. Do not turn that proposal into an established transfer reaction. [Coto et al., 1992](https://doi.org/10.1073/pnas.89.16.7752)

evidence_access

Primary bibliographic record and abstract checked; full methods/figures not comprehensively reviewed.

experimental_contrast

{"intervention": "Zinc addition to metal-depleted FTS", "comparator": "Metal-depleted FTS", "endpoint": "Zinc addition restored classical thymulin rosette-bioassay activity after Chelex metal removal, with best activation at a 1:1 metal-to-peptide ratio.", "effect_direction": "increase", "combination": "single", "conditions": []} Explicit extracted experimental comparison; source-derived draft.

experimental_model

Purified peptide and classical rosette bioassay; Chelex metal removal followed by metal reconstitution.

interpretation_status

Source-derived extraction of a fact-checked reference; access is explicit, not independent raw-data verification.

limitations

Interpret only within the recorded preparation, exposure and comparator. The complete source passage retains qualifications; unspecified doses/timing have not been extracted here. No clinical efficacy, nutrient deficiency or unique molecular mediation is inferred.

plain_language

The peptide needs appropriate zinc association to be active in this assay; zinc is not shown to be consumed by signaling.

primary_references

Contribution of zinc and other metals to the biological activity of the serum thymic factor. | 1982 | DOI 10.1073/pnas.79.17.5370 | PMID 6957870 | https://doi.org/10.1073/pnas.79.17.5370

source_locator

Reviewed reference lines 23-23; exact primary location described in quoted passage where extracted.

Thymulin: detailed mechanisms of action (reviewed 3 October 2026) · lines 23–23

Original AI-assisted review of primary studies and, where relevant, official regulatory records. Access level is retained per claim. Corrections, null results and unresolved questions remain explicit. Not publisher full text or independent replication. · supports · Purified peptide and classical rosette bioassay; Chelex metal removal followed by metal reconstitution. · Recorded from source · Recorded from source

In the foundational experiments, Chelex-mediated metal removal abolished rosette-bioassay activity, and zinc addition restored it. The best activation occurred at a 1:1 metal-to-peptide molar ratio; some other metals produced smaller recoveries. This establishes zinc-dependent activation under those conditions, not a claim that zinc is consumed with every signaling event or that all alternative complexes are inactive. [Dardenne et al., 1982](https://doi.org/10.1073/pnas.79.17.5370)

evidence_access

Primary bibliographic record and abstract checked; full methods/figures not comprehensively reviewed.

experimental_contrast

{"intervention": "Bromocriptine", "comparator": "Control or concurrent prolactin rescue", "endpoint": "Bromocriptine lowered thymulin activity in mice and concurrent prolactin restored it.", "effect_direction": "decrease", "combination": "single", "conditions": []} Explicit extracted experimental comparison; source-derived draft.

experimental_model

Mouse endocrine manipulation; not an established human drug-induced deficiency.

interpretation_status

Source-derived extraction of a fact-checked reference; access is explicit, not independent raw-data verification.

limitations

Interpret only within the recorded preparation, exposure and comparator. The complete source passage retains qualifications; unspecified doses/timing have not been extracted here. No clinical efficacy, nutrient deficiency or unique molecular mediation is inferred.

plain_language

Bromocriptine lowered thymulin activity in mice and concurrent prolactin restored it.

primary_references

Neuroendocrine control of thymic hormonal production. I. Prolactin stimulates in vivo and in vitro the production of thymulin by human and murine thymic epithelial cells. | 1989 | DOI 10.1210/endo-125-1-3 | PMID 2737149 | https://pubmed.ncbi.nlm.nih.gov/2737149/

source_locator

Reviewed reference lines 92-92; exact primary location described in quoted passage where extracted.

Thymulin: detailed mechanisms of action (reviewed 3 October 2026) · lines 92–92

Original AI-assisted review of primary studies and, where relevant, official regulatory records. Access level is retained per claim. Corrections, null results and unresolved questions remain explicit. Not publisher full text or independent replication. · supports · Mouse endocrine manipulation; not an established human drug-induced deficiency. · Recorded from source · Recorded from source

| Prolactin | Increased thymulin secretion in human/mouse TEC cultures. In mice, prolactin increased activity; bromocriptine lowered it, and concurrent prolactin restored it. This is an experimental hormone/drug interaction, not proof that every bromocriptine-treated person develops thymulin deficiency. [1989 study](https://pubmed.ncbi.nlm.nih.gov/2737149/) |

evidence_access

Primary bibliographic record and abstract checked; full methods/figures not comprehensively reviewed.

experimental_condition

Thymulin without EGTA hormone exposure · Thymulin Condition belongs to the full experimental contrast; do not separate a joint intervention.

experimental_condition

Thymulin without EGTA chelation · EGTA Condition belongs to the full experimental contrast; do not separate a joint intervention.

experimental_contrast

{"intervention": "EGTA plus thymulin", "comparator": "Thymulin without EGTA", "endpoint": "EGTA blocked thymulin-stimulated GH release in dispersed rat pituitary preparations; cAMP enhancers potentiated the response.", "effect_direction": "decrease", "combination": "joint", "conditions": [{"entity_slug": "egta", "state": "chelation"}, {"entity_slug": "thymulin", "state": "hormone exposure"}]} Explicit extracted experimental comparison; source-derived draft.

experimental_model

Rat pituitary preparations; extracellular calcium chelation supports calcium-sensitive signaling, not direct calcium binding to thymulin.

interpretation_status

Source-derived extraction of a fact-checked reference; access is explicit, not independent raw-data verification.

limitations

Interpret only within the recorded preparation, exposure and comparator. The complete source passage retains qualifications; unspecified doses/timing have not been extracted here. No clinical efficacy, nutrient deficiency or unique molecular mediation is inferred.

plain_language

EGTA blocked thymulin-stimulated GH release in dispersed rat pituitary preparations; cAMP enhancers potentiated the response.

primary_references

Growth hormone-releasing activity of thymulin on pituitary somatotropes is age dependent. | 1999 | DOI 10.1159/000054399 | PMID 9892847 | https://pubmed.ncbi.nlm.nih.gov/9892847/

source_locator

Reviewed reference lines 106-106; exact primary location described in quoted passage where extracted.

Thymulin: detailed mechanisms of action (reviewed 3 October 2026) · lines 106–106

Original AI-assisted review of primary studies and, where relevant, official regulatory records. Access level is retained per claim. Corrections, null results and unresolved questions remain explicit. Not publisher full text or independent replication. · supports · Rat pituitary preparations; extracellular calcium chelation supports calcium-sensitive signaling, not direct calcium binding to thymulin. · Recorded from source · Recorded from source

In a different dispersed-rat-pituitary study using higher concentrations, thymulin stimulated **GH** release; responses depended on age and concentration. EGTA blocked activity, and cAMP enhancers potentiated it. These interventions support calcium-sensitive signaling, not a requirement for calcium bound directly to thymulin. The earlier GH null remains part of the evidence. [1999 GH study](https://pubmed.ncbi.nlm.nih.gov/9892847/)

evidence_access

Primary bibliographic record and abstract checked; full methods/figures not comprehensively reviewed.

experimental_contrast

{"intervention": "Severe protein-energy malnutrition", "comparator": "Study comparison children", "endpoint": "Severe protein-energy malnutrition was associated with small thymuses and very low thymulin content in postmortem thymuses of 58 Senegalese children.", "effect_direction": "decrease", "combination": "single", "conditions": []} Explicit extracted experimental comparison; source-derived draft.

experimental_model

Human postmortem observational comparison; not controlled intervention or proof of zinc loading defect.

interpretation_status

Source-derived extraction of a fact-checked reference; access is explicit, not independent raw-data verification.

limitations

Interpret only within the recorded preparation, exposure and comparator. The complete source passage retains qualifications; unspecified doses/timing have not been extracted here. No clinical efficacy, nutrient deficiency or unique molecular mediation is inferred.

plain_language

Severe protein-energy malnutrition was associated with small thymuses and very low thymulin content in postmortem thymuses of 58 Senegalese children.

primary_references

Thymulin (facteur thymique serique) and zinc contents of the thymus glands of malnourished children. | 1988 | DOI 10.1093/ajcn/48.2.335 | PMID 3136643 | https://pubmed.ncbi.nlm.nih.gov/3136643/

source_locator

Reviewed reference lines 116-116; exact primary location described in quoted passage where extracted.

Thymulin: detailed mechanisms of action (reviewed 3 October 2026) · lines 116–116

Original AI-assisted review of primary studies and, where relevant, official regulatory records. Access level is retained per claim. Corrections, null results and unresolved questions remain explicit. Not publisher full text or independent replication. · supports · Human postmortem observational comparison; not controlled intervention or proof of zinc loading defect. · Recorded from source · Recorded from source

A crucial counterexample comes from postmortem thymuses of 58 Senegalese children. Severe protein-energy malnutrition was associated with small thymuses and very low thymulin content, **without depleted thymic zinc content**. This observational study cannot resolve intracellular zinc delivery, but it shows why reduced thymulin should not automatically be assigned to insufficient total tissue zinc. [Jambon et al., 1988](https://pubmed.ncbi.nlm.nih.gov/3136643/)

evidence_access

Primary bibliographic record and abstract checked; full methods/figures not comprehensively reviewed.

experimental_contrast

{"intervention": "Severe protein-energy malnutrition", "comparator": "Study comparison children", "endpoint": "Low thymulin content in the child malnutrition study occurred without depleted total thymic zinc; total zinc does not resolve subcellular availability.", "effect_direction": "no_detected_change", "combination": "single", "conditions": []} Explicit extracted experimental comparison; source-derived draft.

experimental_model

Human postmortem thymuses, 58 Senegalese children; observational association.

interpretation_status

Source-derived extraction of a fact-checked reference; access is explicit, not independent raw-data verification.

limitations

Interpret only within the recorded preparation, exposure and comparator. The complete source passage retains qualifications; unspecified doses/timing have not been extracted here. No clinical efficacy, nutrient deficiency or unique molecular mediation is inferred.

plain_language

Low thymulin content in the child malnutrition study occurred without depleted total thymic zinc; total zinc does not resolve subcellular availability.

primary_references

Thymulin (facteur thymique serique) and zinc contents of the thymus glands of malnourished children. | 1988 | DOI 10.1093/ajcn/48.2.335 | PMID 3136643 | https://pubmed.ncbi.nlm.nih.gov/3136643/

source_locator

Reviewed reference lines 116-116; exact primary location described in quoted passage where extracted.

Thymulin: detailed mechanisms of action (reviewed 3 October 2026) · lines 116–116

Original AI-assisted review of primary studies and, where relevant, official regulatory records. Access level is retained per claim. Corrections, null results and unresolved questions remain explicit. Not publisher full text or independent replication. · supports · Human postmortem thymuses, 58 Senegalese children; observational association. · Recorded from source · Recorded from source

A crucial counterexample comes from postmortem thymuses of 58 Senegalese children. Severe protein-energy malnutrition was associated with small thymuses and very low thymulin content, **without depleted thymic zinc content**. This observational study cannot resolve intracellular zinc delivery, but it shows why reduced thymulin should not automatically be assigned to insufficient total tissue zinc. [Jambon et al., 1988](https://pubmed.ncbi.nlm.nih.gov/3136643/)

evidence_access

Primary bibliographic record and abstract checked; full methods/figures not comprehensively reviewed.

experimental_contrast

{"intervention": "Melatonin during stress", "comparator": "Study control", "endpoint": "Melatonin accompanied changes in zinc balance, thymulin and IL-2 in stressed tumor-bearing mice; co-movement did not establish thymulin mediation of tumor outcomes.", "effect_direction": "mixed", "combination": "single", "conditions": []} Explicit extracted experimental comparison; source-derived draft.

experimental_model

Stressed tumor-bearing mouse model.

interpretation_status

Source-derived extraction of a fact-checked reference; access is explicit, not independent raw-data verification.

limitations

Interpret only within the recorded preparation, exposure and comparator. The complete source passage retains qualifications; unspecified doses/timing have not been extracted here. No clinical efficacy, nutrient deficiency or unique molecular mediation is inferred.

plain_language

Melatonin accompanied changes in zinc balance, thymulin and IL-2 in stressed tumor-bearing mice; co-movement did not establish thymulin mediation of tumor outcomes.

primary_references

Melatonin administration in tumor-bearing mice (intact and pinealectomized) in relation to stress, zinc, thymulin and IL-2. | 1999 | DOI 10.1016/s0192-0561(98)00067-8 | PMID 10411280 | https://pubmed.ncbi.nlm.nih.gov/10411280/

source_locator

Reviewed reference lines 96-96; exact primary location described in quoted passage where extracted.

Thymulin: detailed mechanisms of action (reviewed 3 October 2026) · lines 96–96

Original AI-assisted review of primary studies and, where relevant, official regulatory records. Access level is retained per claim. Corrections, null results and unresolved questions remain explicit. Not publisher full text or independent replication. · supports · Stressed tumor-bearing mouse model. · Recorded from source · Recorded from source

| Melatonin and stress | In a stressed, tumor-bearing mouse model, melatonin treatment accompanied changes in zinc balance, thymulin and IL-2. Co-movement does not prove a direct melatonin → thymulin receptor pathway or that thymulin mediated the tumor outcome. [1999 study](https://pubmed.ncbi.nlm.nih.gov/10411280/) |

evidence_access

Primary bibliographic record and abstract checked; full methods/figures not comprehensively reviewed.

experimental_contrast

{"intervention": "IL-1 exposure", "comparator": "Untreated cultures", "endpoint": "IL-1 increased metallothionein mRNA in human TEC cultures; direct metallothionein-to-FTS zinc transfer remained proposed rather than measured.", "effect_direction": "increase", "combination": "single", "conditions": []} Explicit extracted experimental comparison; source-derived draft.

experimental_model

Human TECs; metallothionein transcript measurement, isoform unresolved.

interpretation_status

Source-derived extraction of a fact-checked reference; access is explicit, not independent raw-data verification.

limitations

Interpret only within the recorded preparation, exposure and comparator. The complete source passage retains qualifications; unspecified doses/timing have not been extracted here. No clinical efficacy, nutrient deficiency or unique molecular mediation is inferred.

plain_language

IL-1 increased metallothionein mRNA in human TEC cultures; direct metallothionein-to-FTS zinc transfer remained proposed rather than measured.

primary_references

Interleukin 1 regulates secretion of zinc-thymulin by human thymic epithelial cells and its action on T-lymphocyte proliferation and nuclear protein kinase C. | 1992 | DOI 10.1073/pnas.89.16.7752 | PMID 1502195 | https://doi.org/10.1073/pnas.89.16.7752

source_locator

Reviewed reference lines 35-35; exact primary location described in quoted passage where extracted.

Thymulin: detailed mechanisms of action (reviewed 3 October 2026) · lines 35–35

Original AI-assisted review of primary studies and, where relevant, official regulatory records. Access level is retained per claim. Corrections, null results and unresolved questions remain explicit. Not publisher full text or independent replication. · supports · Human TECs; metallothionein transcript measurement, isoform unresolved. · Recorded from source · Recorded from source

In cultured human TECs, **IL-1α and IL-1β increased zinc uptake, metallothionein mRNA and secretion of biologically active thymulin**. Part of the IL-1 effect on zinc uptake occurred independently of proliferation. Metallothionein was proposed as an intracellular zinc donor; direct transfer from a defined metallothionein molecule to FTS was not resolved by these observations. Do not turn that proposal into an established transfer reaction. [Coto et al., 1992](https://doi.org/10.1073/pnas.89.16.7752)

evidence_access

Full text obtained; relevant results/methods inspected. This does not assert exhaustive figure/data reanalysis.

experimental_condition

Study control mice overexpression · Experimental mouse metallothionein overexpression Condition belongs to the full experimental contrast; do not separate a joint intervention.

experimental_contrast

{"intervention": "Metallothionein overexpression under stress", "comparator": "Study control mice", "endpoint": "Stressed metallothionein-overexpressing mice had reduced active thymulin despite normal-range plasma zinc and preserved zinc-recoverable thymulin activity.", "effect_direction": "decrease", "combination": "joint", "conditions": [{"entity_slug": "mouse-metallothionein-overexpression", "state": "overexpression"}, {"entity_slug": null, "state": "experimental stress"}]} Explicit extracted experimental comparison; source-derived draft.

experimental_model

Stressed metallothionein-overexpressing mice; liver zinc storage, plasma zinc and thymic changes were distinct measurements.

interpretation_status

Source-derived extraction of a fact-checked reference; access is explicit, not independent raw-data verification.

limitations

Interpret only within the recorded preparation, exposure and comparator. The complete source passage retains qualifications; unspecified doses/timing have not been extracted here. No clinical efficacy, nutrient deficiency or unique molecular mediation is inferred.

plain_language

Stressed metallothionein-overexpressing mice had reduced active thymulin despite normal-range plasma zinc and preserved zinc-recoverable thymulin activity.

primary_references

Metallothioneins (I+II) and thyroid–thymus axis efficiency in old mice: role of corticosterone and zinc supply | 2002 | DOI 10.1016/S0047-6374(01)00414-6 | PMID 11850030 | https://pmc.ncbi.nlm.nih.gov/articles/PMC7127331/

source_locator

Reviewed reference lines 48-48; exact primary location described in quoted passage where extracted.

Thymulin: detailed mechanisms of action (reviewed 3 October 2026) · lines 48–48

Original AI-assisted review of primary studies and, where relevant, official regulatory records. Access level is retained per claim. Corrections, null results and unresolved questions remain explicit. Not publisher full text or independent replication. · supports · Stressed metallothionein-overexpressing mice; liver zinc storage, plasma zinc and thymic changes were distinct measurements. · Recorded from source · Recorded from source

Metallothionein is not simply beneficial or harmful. A 2002 mouse study found that stressed metallothionein-overexpressing animals had reduced active thymulin and NK-cell activity despite normal-range plasma zinc and preserved zinc-recoverable thymulin activity. Higher corticosterone, liver zinc–metallothionein and reduced thymic cortex accompanied the phenotype. This supports investigating **zinc distribution and stress**, but does not prove that metallothionein directly starved the peptide in TECs or mediated every immune change. Liver storage, TEC delivery and serum bioactivity are different compartments and measurements. [Mouse stress and zinc-distribution study](https://pmc.ncbi.nlm.nih.gov/articles/PMC7127331/)

availability_state

nutrient_deficiency Imported condition classification; unverified.

evidence_access

Primary bibliographic record and abstract checked; full methods/figures not comprehensively reviewed.

experimental_contrast

{"intervention": "Mild zinc deficiency or controlled dietary depletion", "comparator": "Zinc-replete or repleted comparison", "endpoint": "Mild zinc deficiency was accompanied by reduced thymulin bioactivity despite normal plasma zinc in the small human study; repletion or laboratory zinc treatment restored activity.", "effect_direction": "decrease", "combination": "single", "conditions": []} Explicit extracted experimental comparison; source-derived draft.

experimental_model

Two dietary-depletion volunteers; six mildly zinc-deficient sickle-cell adults and six without sickle-cell anemia. Not population diagnostic validation.

interpretation_status

Source-derived extraction of a fact-checked reference; access is explicit, not independent raw-data verification.

limitations

Interpret only within the recorded preparation, exposure and comparator. The complete source passage retains qualifications; unspecified doses/timing have not been extracted here. No clinical efficacy, nutrient deficiency or unique molecular mediation is inferred.

plain_language

Mild zinc deficiency was accompanied by reduced thymulin bioactivity despite normal plasma zinc in the small human study; repletion or laboratory zinc treatment restored activity.

primary_references

Serum thymulin in human zinc deficiency. | 1988 | DOI 10.1172/jci113717 | PMID 3262625 | https://www.jci.org/articles/view/113717

source_locator

Line 1 of the separately retained human zinc/thymulin excerpt; originally in the reviewed thymulin reference.

trigger_kind

nutrient_deficiency Imported condition classification; unverified.

Zinc availability and human thymulin bioactivity: study excerpt · lines 1–1

Exact excerpt from the 3 October 2026 reviewed thymulin reference. Primary study: Prasad et al. 1988, https://www.jci.org/articles/view/113717. Small human proof of concept; not population diagnostic validation. · supports · Two dietary-depletion volunteers; six mildly zinc-deficient sickle-cell adults and six without sickle-cell anemia. Not population diagnostic validation. · Recorded from source · Recorded from source

The strongest small human study included two dietary-depletion volunteers, six mildly zinc-deficient adults with sickle-cell anemia and six without it. Plasma zinc was normal, while cellular zinc assessments suggested deficiency. Thymulin bioactivity fell and recovered with zinc repletion or laboratory zinc treatment; immune readouts also changed. This demonstrates a useful **human proof of concept**, not population-wide diagnostic accuracy or proof that thymulin mediated every benefit of zinc. [Prasad et al., 1988](https://www.jci.org/articles/view/113717)